JPH0390034A - Production of helodermin and use thereof - Google Patents

Production of helodermin and use thereof

Info

Publication number
JPH0390034A
JPH0390034A JP1226851A JP22685189A JPH0390034A JP H0390034 A JPH0390034 A JP H0390034A JP 1226851 A JP1226851 A JP 1226851A JP 22685189 A JP22685189 A JP 22685189A JP H0390034 A JPH0390034 A JP H0390034A
Authority
JP
Japan
Prior art keywords
group
bzl
leu
boc
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1226851A
Other languages
Japanese (ja)
Inventor
Hitoshi Kimura
仁 木村
Nobuhiro Katsumata
勝又 信宏
Mitsugi Hachisu
蜂須 貢
Toyoichi Hiranuma
豊一 平沼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
M&D Research Co Ltd
Original Assignee
M&D Research Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M&D Research Co Ltd filed Critical M&D Research Co Ltd
Priority to JP1226851A priority Critical patent/JPH0390034A/en
Publication of JPH0390034A publication Critical patent/JPH0390034A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PURPOSE:To industrially obtain helodermin in high purity and yield by synthesizing a protected helodermin that is a new intermediate in which all the side-chain functional groups of constituent amino acids are protected and then removing the protecting groups. CONSTITUTION:An undecapeptide expressed by formula I (Boc is tert- butyloxycarbonyl; Bzl is benzyl; OcHex is cyclohexyl ester; Br-Z is 2- bromobenzyloxycarbonyl; X is tosyl or H) is condensed with a tetracosapeptide amide expressed by formula II (Cl-Z is 2-chlorobenzyloxycarbonyl; X2 is tosyl or mesitylene-2-sulfonyl) to provide a pentatriacosapeptide amide expressed by formula III. Protecting groups of the resultant pentatriacosapeptide amide are then removed with a strong acid (e.g. hydrogen fluoride or trifluoromethanesulfonic acid) to afford helodermin expressed by formula IV. The helodermin obtained by the aforementioned method is capable of acting not only on bloodstream but also specifically on musculus trachealis and used as a remedy for asthma.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、医薬として有用なペプチド、ヘロデルミン(
Helodern+in)の医薬としての用途、及びそ
の製造法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention provides a pharmaceutically useful peptide, helodermin (
The present invention relates to the pharmaceutical use of Helodern+in) and its manufacturing method.

〔発明の背景・従来技術〕[Background of the invention/prior art]

最近のペプチドホルモンに関する研究の進歩により、消
化管に存在するペプチドホルモンの多くは、脳にも存在
し、逆に脳で発見されたホルモンの多数が消化管にも認
められることが判り、これらのホルモンは脳−腸管ペブ
チ)’ (Brain−gut peptide)と呼
称され、これらホルモンに関する研究が神経内分泌学と
して脚光を浴びている。
Recent advances in research on peptide hormones have revealed that many of the peptide hormones present in the gastrointestinal tract also exist in the brain, and conversely, many hormones discovered in the brain are also found in the gastrointestinal tract. Hormones are called brain-gut peptides, and research on these hormones has been in the spotlight as neuroendocrinology.

1982年ジエー、ビイー、ラウフマン(J、 P。1982 G., B., and Laufman (J., P.).

Raufman)等(アメリカン ジャーナル オブフ
ィジオロジ−(Am、 J、 Physiol、)、2
42. G470(1982) )が毒トカゲG11a
 Monster(Helodermasupectu
+m)の毒液中に、脳−腸管ペプチドの代表であるVI
P(Vasoactive Intestinal P
o1ypeptide)と類似した活性を示す物質が存
在することを示した。この物質は1984年星野等(フ
ェブス レターズ(FEBS Lett、)、178.
233(1984))により35個のアミノ酸よりなる
分子量3845.5のペプチド(ヘロデルミン)で、次
の式Cl)に示すようなアミノ酸配列を有する事が決定
された。
Raufman) et al. (American Journal of Physiology (Am, J, Physiol), 2
42. G470 (1982)) is a poisonous lizard G11a
Monster (Helodermasupectu)
VI, a representative brain-intestinal peptide, was present in the venom of +m).
P (Vasoactive Intestinal P
It was shown that there is a substance that exhibits an activity similar to that of olypeptide. This substance was described in Hoshino et al. (FEBS Lett, 1984), 178.
233 (1984)), it was determined to be a peptide (herodermin) consisting of 35 amino acids and having a molecular weight of 3845.5, and having an amino acid sequence as shown in the following formula (Cl).

本ヘロデルミンはラットやモルモットの膵臓を用いた実
験で、セクレチンやVIPと同様アデニレートシクラー
ゼの活性を上昇させ、細胞内cAMPを増加させる(例
えば、ビー、ロベレヒト(P、 Robberecht
)ら、フェブス、レターズ(FEBSLerrers)
、 Vol、166、277 (1984) ) 、ま
たイヌを用いた実験で、麻酔下に動脈内に投与すると用
量依存的に大腿動脈血流を増加させる。ヘロデルミンの
この作用は、VIPの1/16と弱いが、作用持続時間
はVIPのそれより長く、その半減期はVIPの約6倍
である。また血流増加作用の他に、ヘロデルミンの静脈
内投与によって、持続性の血圧低下と心頻拍が誘発され
頚動脈血流が増加する(例えば、ニス、ナルセ(S、 
Naruse)ら(ペブタイズ(Peptides)、
 Vol、 7,5upp1.1+237 (1986
))。
In experiments using the pancreas of rats and guinea pigs, this helodermin increases the activity of adenylate cyclase, similar to secretin and VIP, and increases intracellular cAMP (for example, P. Robberecht
), Febs, Letters (FEBSLerrrers)
, Vol. 166, 277 (1984)), and in experiments using dogs, it dose-dependently increased femoral artery blood flow when administered intraarterially under anesthesia. This effect of helodermin is 1/16 weaker than that of VIP, but the duration of action is longer than that of VIP, and its half-life is about 6 times that of VIP. In addition to its effect on increasing blood flow, intravenous administration of helodermin induces a sustained decrease in blood pressure and cardiac tachycardia, and increases carotid blood flow (e.g., Nis, Narce (S),
Naruse et al. (Peptides,
Vol, 7,5upp1.1+237 (1986
)).

ヘロデルごンは従来上述したように毒トカゲの毒液中か
ら単離されたが、資源上の問題もあり、現在は化学合成
法で製造されている。その製造法としてはビー、ロベル
ヒト(P、 Robberecht)ら(ペプタイズ(
Peptides)、 Vol、 7.5uppl。
As mentioned above, helodergon was previously isolated from the venom of a poisonous lizard, but due to resource issues, it is currently produced by chemical synthesis. As for its production method, P, Robberecht et al.
Peptides), Vol, 7.5uppl.

1、79 (1986)) 、ニス、ナルセ(S、 N
aruse)ら(ベブタイズ(Peptides)、 
Vol、 7.5upp1. L237 (1986)
)の固相法を用いた製法が報告されている。
1, 79 (1986)), Niss, Narce (S, N
(Peptides),
Vol, 7.5upp1. L237 (1986)
) has been reported using a solid phase method.

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

しかしながら、これらの既知方法は多量のヘロデルミン
を能率良く製造することについては、あまり検討されて
おらず、ヘロデルミンを工業的に有利に合成する方法と
は言い難い。即ち、上記の如くヘロデルミンは構造的に
35個のアミノ酸を構成成分とするペプチドであるので
、工業的にヘロデル逅ンを高純度、高収率で得ようとす
るためには、例えば保護基として何を選択するか、脱離
の条件をいかにするか、精製法をどうするかなど解決し
なければならない困難な問題が多い。上記の既知方法は
すべて固相法であるから、合成された未精製ペプチドよ
り目的トスるヘロデル主ンを単離するためには、極めて
困難な精製方法を利用する必要が−ある。
However, these known methods have not been studied much in terms of efficiently producing large amounts of helodermin, and cannot be said to be industrially advantageous methods for synthesizing helodermin. That is, as mentioned above, helodermine is a peptide that structurally consists of 35 amino acids, so in order to industrially obtain helodermin with high purity and high yield, it is necessary to use, for example, a protective group. There are many difficult problems that must be solved, such as what to choose, what to do with the desorption conditions, and what to do with the purification method. Since all of the above-mentioned known methods are solid-phase methods, it is necessary to use extremely difficult purification methods in order to isolate the target Herodel main protein from the synthesized unpurified peptide.

またヘロデルミン自身の用途としても、血流に対する作
用のみでは生理活性ペプチドVIPなどと比較し優位性
が認められない。
Furthermore, as for the use of helodermin itself, it is not superior to physiologically active peptides such as VIP in terms of its effect on blood flow alone.

〔課題を解決するための手段〕[Means to solve the problem]

本発明者らは、更に有利で、活性の高い、しかも工業的
なヘロデル旦ンの合成力法、精製方法及びその用途につ
いて鋭意研究を重ねた結果、ヘロデルミンの合成に有用
な新規中間体である保護ヘロデルミンを見出し、この保
護ヘロデルミンより15%の収率で高純度の合成ヘロデ
ルミンが得られることを見出した。また、同時にこの保
護ヘロデルミンの合成法を確立し、及びヘロデルミンの
新しい作用として気管筋に対し、特異的に作用すること
を見出し、本発明を完成するに至った。
The present inventors have conducted intensive research on more advantageous, highly active, and industrial methods for synthesizing and purifying helodermine, and have discovered a novel intermediate useful for the synthesis of helodermin. They discovered protected herodermin and found that highly pure synthetic herodermin can be obtained from this protected herodermin in a yield of 15%. At the same time, we established a method for synthesizing this protected helodermin, and discovered that helodermin has a new action that specifically acts on tracheal muscles, leading to the completion of the present invention.

即ち、本発明は、次の構造式(n)で示されるペンタト
リアコサペプチドアミド、及びその保護基を除去するこ
とを特徴とするヘロデルミンの製造方法、並びにヘロデ
ルミンの新しい用途、即ちヘロデルミンを主成分とする
喘息治療薬を提供するものである。
That is, the present invention provides a pentatriacosapeptide amide represented by the following structural formula (n), a method for producing helodermin characterized by removing its protective group, and a new use of helodermin, that is, a method for producing helodermin, which is characterized by removing helodermin as a main component. The objective is to provide a drug for treating asthma.

Boc−His(X+)−Set(Bzl)−Asp(
OcHex)−Ala−11e−Phe−Thr(Bz
l)−Gln−Gln−Tyr(Br−Z)−3er(
Bzl)−Lys (Cl−Z)−Leu−Leu−A
la−Lys (C1−Z)−Leu−Ala−Leu
−Gln−Lys (Cl−Z)−Tyr(Br−Z)
 −Leu−Ala−3er(Bzl)−11e−Le
u−Gly−3er(Bzl)−Arg(Xg)−Th
r(Bzl)−3et(Bzl)−Pro−Pro−P
ro−NHz  ・・・(II )(式中、Bocはタ
ーシャリ−ブチルオキシカルボニル基、Bzlはベンジ
ル基、0cRexはシクロヘキシルエステル基、Br4
は2−ブロモベンジルオキシカルボニル基、Cl−Zは
2−クロロベンジルオキシカルボニル基、X、はトシル
(Tos)基または水素原子、x2はトシル基またはメ
シチレン−2−スルフォニル(Mts)基を示す。)な
お、本明細書において、アミノ酸、ペプチドに関して略
号を用いる場合はIUPAC,IUBの規定、あるいは
当該分野における慣用記号に従うものとし、その例を次
に挙げる。またア逅ノ酸等に関して光学異性体が有り得
る場合は、特に明記しなければ1体を示すものとする。
Boc-His(X+)-Set(Bzl)-Asp(
OcHex)-Ala-11e-Phe-Thr(Bz
l)-Gln-Gln-Tyr(Br-Z)-3er(
Bzl)-Lys (Cl-Z)-Leu-Leu-A
la-Lys (C1-Z)-Leu-Ala-Leu
-Gln-Lys (Cl-Z)-Tyr(Br-Z)
-Leu-Ala-3er(Bzl)-11e-Le
u-Gly-3er(Bzl)-Arg(Xg)-Th
r(Bzl)-3et(Bzl)-Pro-Pro-P
ro-NHz...(II) (In the formula, Boc is a tertiary-butyloxycarbonyl group, Bzl is a benzyl group, 0cRex is a cyclohexyl ester group, Br4
represents a 2-bromobenzyloxycarbonyl group, Cl-Z represents a 2-chlorobenzyloxycarbonyl group, X represents a tosyl (Tos) group or a hydrogen atom, and x2 represents a tosyl group or a mesitylene-2-sulfonyl (Mts) group. ) In this specification, when abbreviations are used for amino acids and peptides, they shall comply with the regulations of IUPAC, IUB, or common symbols in the field, and examples thereof are listed below. Furthermore, if an optical isomer is possible for an anoic acid or the like, only one isomer is shown unless otherwise specified.

Ala  :アラニン   ^rg:アルギニンAsp
  :アスパラギン酸 Gin  :グルタミンGly
 ニゲリシン   His :ヒスチジン11e :イ
ソロイシン Leu :ロイシンLys  :リジン 
   Phe :フェニルアラニンPro ニブロリン
   Ser :セリンThr :スレオニン  Ty
r :チロシン上述の構造式(II)で明らかなごとく
、本発明の特徴は、アスパラギン酸の側鎖官能基をシク
ロヘキシル基、セリン、スレオニンの側鎖官能基をベン
ジル基、ヒスチジンの側鎖官能基をトシル基、アルギニ
ンの側鎖官能基をトシル基またはメシチレン−2−スル
フォニル基、チロシンの側鎖官能基を2−ブロモベンジ
ルオキシカルボニル基、リジンの側鎖官能基を2−クロ
ロベンジルオキシカルボニル基で保護した保護ヘロデル
ミンを用いた点である。従来、このような最大保護法を
用いて、液相法でヘロデルごンを合成した例はなく、本
発明は工業的スケールでヘロデルミンを製造できるとい
う特徴を有する。
Ala: Alanine ^rg: Arginine Asp
: Aspartic acid Gin : Glutamine Gly
Nigericin His: Histidine 11e: Isoleucine Leu: Leucine Lys: Lysine
Phe: Phenylalanine Pro Nibroline Ser: Serine Thr: Threonine Ty
r: Tyrosine As is clear from the above structural formula (II), the feature of the present invention is that the side chain functional group of aspartic acid is a cyclohexyl group, the side chain functional group of serine and threonine is a benzyl group, and the side chain functional group of histidine is a cyclohexyl group. tosyl group, the side chain functional group of arginine to tosyl group or mesitylene-2-sulfonyl group, the side chain functional group of tyrosine to 2-bromobenzyloxycarbonyl group, and the side chain functional group of lysine to 2-chlorobenzyloxycarbonyl group. The point is that protected herodermin was used. Conventionally, there has been no example of synthesizing helodermine by a liquid phase method using such a maximum protection method, and the present invention is characterized in that helodermine can be produced on an industrial scale.

本発明においてヘロデル主ンを製造する際には、次の構
造式 %式% ) (式中、Bocはターシャリ−ブチルオキシカルボニル
基、Bzlはベンジル基、0cHeにはシクロヘキシル
エステル基、Br−Zは2−ブロモベンジルオキシカル
ボニル基、xlはトシル基または水素原子を示す) で示されるウンデカペプチドを、次の構造式8式% ) (式中、Cl−Zは2−クロロベンジルオキシカルボニ
ル基、Xiはトシル基またはメシチレン−2−スルフォ
ニル基を示す) で示されるテトラコサペブチドアξドと縮合させて得ら
れた次の構造式 %式% () ) で示されるペンタトリアコサベブチドア泉ドの保護基を
適当な方法により除去しさえすればよい。除去する方法
は問わないが、好ましい結果を与える一例を挙げれば、
フッ化水素やトリフルオロメタンスルフォン酸のごとき
強酸で処理することにより、短時間、低温で一挙に除去
する方法が挙げられる。
In the present invention, when producing Herodel main chain, the following structural formula (%) is used: (In the formula, Boc is a tertiary-butyloxycarbonyl group, Bzl is a benzyl group, 0cHe is a cyclohexyl ester group, and Br-Z is a 2-bromobenzyloxycarbonyl group, xl represents a tosyl group or a hydrogen atom). Xi represents a tosyl group or a mesitylene-2-sulfonyl group) A pentatriacosabebutidore represented by the following structural formula % Formula % () ) obtained by condensation with a tetracosapebutide ξ-d represented by It is only necessary to remove the protective group of Izumi Do by a suitable method. There are no restrictions on the method of removal, but an example that gives a favorable result is:
An example of this method is to treat with a strong acid such as hydrogen fluoride or trifluoromethanesulfonic acid to remove it all at once at a low temperature in a short period of time.

本発明の方法により得られたヘロデルミンは、例えば次
に述べるごとく、極めて簡単な方法で精製することがで
き、工業的にもたいへん有利な方法である。即ち、上述
した保護ヘロデルミンの保護基をフッ化水素やトリフル
オロメタンスルフォン酸などの強酸で一挙に除去し、常
法によりカルボキシメチルセルロースを用い、濃度の異
なる酢酸アンモニウム溶液によるカラムクロマトグラフ
ィー、及び逆相液体クロマトグラフィーにより、高純度
ヘロデルミンを収率良く得ることができる。
Herodermin obtained by the method of the present invention can be purified by an extremely simple method, for example as described below, and is a very advantageous method from an industrial perspective. That is, the protecting groups of the above-mentioned protected herodermine were removed all at once with a strong acid such as hydrogen fluoride or trifluoromethanesulfonic acid, and column chromatography using carboxymethyl cellulose with ammonium acetate solutions of different concentrations using a conventional method, and reverse phase liquid chromatography. High purity helodermin can be obtained in good yield by chromatography.

本発明に用いられる保護ヘロデルミンの製造方法として
は種々考えられるが、本発明者が合成した方法は次の通
りである。
Although various methods can be considered for producing the protected herodermin used in the present invention, the method synthesized by the present inventor is as follows.

即ち、上述のヘロデルミンの構造式(1)において構成
アミノ酸に左のN端より番号を付したが、基本的には次
の5つのフラグメント、即ちフラグメント^として1−
11の保護されたペプチド、具体的にはBoc−His
(X+)−Ser(Bzl)−Asp(OcHex)−
Ala−11e−Phe−Thr(Bzl)−Gin−
Gill−Tyr(Br−Z)−3er(Bzl)−0
H(Lは水素原子またはトシル基)、フラグメントBと
して12−18の保護されたペプチド、具体的にはBo
c−Lys (C1−Z) −Leu−Leu−、Al
a−Lys(Cl−Z)−Leu−Ala−:OH,フ
ラグメントCとして19−23の保護されたペプチド、
具体的にはBoc−Leu−Gln−Lys(C1−Z
)−Tyr(Br−Z)−Leu−OH。
That is, in the above-mentioned structural formula (1) of helodermin, the constituent amino acids are numbered from the left N-terminus, but basically there are the following five fragments, that is, 1-
11 protected peptides, specifically Boc-His
(X+)-Ser(Bzl)-Asp(OcHex)-
Ala-11e-Phe-Thr(Bzl)-Gin-
Gill-Tyr(Br-Z)-3er(Bzl)-0
H (L is a hydrogen atom or a tosyl group), a protected peptide of 12-18 as fragment B, specifically Bo
c-Lys (C1-Z) -Leu-Leu-, Al
a-Lys(Cl-Z)-Leu-Ala-:OH, protected peptide of 19-23 as fragment C,
Specifically, Boc-Leu-Gln-Lys (C1-Z
)-Tyr(Br-Z)-Leu-OH.

フラグメントDとして24−28の保護されたペプチド
、具体的にはBoc−^1a−Ser(Bzl)−11
e−Leu−Gly−01(、フラグメントEとして2
9−35の保護されたペプチド、具体的にはBoc−S
et(Bzl)−^rg(Xz)−Thr(Bzl)−
Ser(Bzl)−Pro−Pro−Pro−NHz 
(Xzはトシル基またはメタンスルフォニル基)をそれ
ぞれ合成し、ついで上記のフラグメントD、 Eを縮合
し、新たに24−35の保護されたペプチドとし、これ
にフラグメントC1次いでフラグメントB、最後にフラ
グメンI−Aを縮合させて前記構造式(II)で示され
る保護されたヘロデルミンを合成した。これらの合或は
各構成アミノ酸側鎖を全部保護しているため、望ましく
ない副反応が少なく、ペプチド台底で通常行われている
縮合法、精製法により台底される。
24-28 protected peptide as fragment D, specifically Boc-^1a-Ser(Bzl)-11
e-Leu-Gly-01 (, 2 as fragment E
9-35 protected peptide, specifically Boc-S
et(Bzl)-^rg(Xz)-Thr(Bzl)-
Ser(Bzl)-Pro-Pro-Pro-NHz
(Xz is a tosyl group or a methanesulfonyl group), and then the above fragments D and E are condensed to create a new protected peptide of 24-35, followed by fragment C1, then fragment B, and finally fragment I. -A was condensed to synthesize protected herodermin represented by the above structural formula (II). Since the side chains of these or each of the constituent amino acids are completely protected, there are few undesirable side reactions, and the peptides can be processed by condensation and purification methods that are commonly used for peptide processing.

この様にして得られた合成ヘロデルミンを用いてその生
理活性について種々摘出臓器を用いて詳しく検討した結
果、モルモットの気管平滑筋に対し特異的な作用が見出
された。
As a result of detailed investigation of the physiological activity of the synthetic helodermin obtained in this way using various isolated organs, it was found that it has a specific action on the tracheal smooth muscle of guinea pigs.

〔発明の効果〕〔Effect of the invention〕

本発明により、医薬として有用なペプチド、ヘロデルミ
ンを工業的に有利に合成することが可能になったと同時
に、このヘロデルミンが気管支喘息等の喘息治療薬とし
て有用であることが明らかとなった。
The present invention has made it possible to industrially advantageously synthesize helodermin, a peptide useful as a medicine, and at the same time, it has become clear that helodermin is useful as a therapeutic agent for asthma such as bronchial asthma.

〔実施例〕〔Example〕

以下、実施例により本発明を更に詳細に説明するが、本
発明はこれらの実施例に限定されるものではない。
EXAMPLES Hereinafter, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples.

実施例1 (ラットおよびモルモット心房筋に対する作
用) ラットあるいはモノモットを放血後直ちに心臓を摘出し
、心房と心室を分離した後95%O1+5%COtを通
気したクレブスヘンゼライト成製を満たしたマグヌス管
中に心房筋を懸垂した。
Example 1 (Effect on atrial muscle of rats and guinea pigs) Immediately after exsanguination of rats or monopigs, the heart was removed, the atrium and ventricle were separated, and then a Magnus tube filled with Krebs-Henseleit was insufflated with 95% O1 + 5% COt. The atrial muscle was suspended inside.

張力はFDビックアンプを介しポリグラフ363(日本
電気三栄)上に記録した。被験物質は低用量より累積的
に投与し、投与前を100%とし変化値を%で現した。
The tension was recorded on a Polygraph 363 (NEC Sanei) via an FD big amplifier. The test substance was administered cumulatively starting from a low dose, and the change value was expressed as a percentage with the pre-administration value set as 100%.

結果は図1に示した。また、EDS。値を算出し表1に
示した。
The results are shown in Figure 1. Also, EDS. The values were calculated and shown in Table 1.

実施例2(モルモット気管筋に対する作用)モルモット
を放血致死させ気管を摘出後輪切りにし、これを連結し
気管鎖標本を作製した。
Example 2 (Effect on Guinea Pig Tracheal Muscles) A guinea pig was sacrificed by exsanguination, and the trachea was removed and cut into slices, which were connected to prepare a tracheal chain specimen.

この気管鎖標本をタイロード成製を満たしたマグヌス管
中に懸垂し、アイソトーニソクトランスジェー、サーを
介してポリグラフ363(日本電気三栄)上に張力を記
録した。実験は3X10−’Mヒスタミンで予め収縮さ
せ、被験物質を低用量より累積的に投与し弛緩反応を観
察した。その後2X10−”Mイソプロテレノールを投
与しこの反応を100%弛緩作用とした。実験結果より
EDS。(50%有効濃度〉値を算出した。結果は図2
および表1に示した。
This tracheal chain specimen was suspended in a Magnus tube filled with Tyrode's tube, and the tension was recorded on a Polygraph 363 (Nippon Electric Sanei) via an isotonic transducer. In the experiment, the animals were precontracted with 3x10-'M histamine, and the test substance was cumulatively administered at lower doses to observe the relaxation response. After that, 2X10-''M isoproterenol was administered, and this reaction was defined as a 100% relaxation effect.The EDS (50% effective concentration) value was calculated from the experimental results.The results are shown in Figure 2.
and shown in Table 1.

実施例3 (モルモット回腸に対する作用)モルモット
を放血致死後回腸を摘出し、約IC−の回腸切片をタイ
ロード成製を満たしたマグヌス管中に懸垂し、アイソト
ーニツタトランスジューサーを介しポリグラフ363(
日本電気三栄)上に張力を記録した。実験はモルモット
気管の場合と同様に行い、結果を図3に示した。また、
6口、。値を算出し表1に示した。
Example 3 (Effect on guinea pig ileum) After killing the guinea pig by exsanguination, the ileum was removed, and the ileal section of approximately IC− was suspended in a Magnus tube filled with Tyrode's tube.
The tension was recorded on the NEC Sanei). The experiment was conducted in the same manner as in the case of guinea pig trachea, and the results are shown in FIG. Also,
6 bites. The values were calculated and shown in Table 1.

実施例4(家兎胸部大動脈に対する作用)家兎を放血致
死させ開胸により胸部大動脈を摘出し輪切りにした後−
片を切開し血管条片とした。これを95%O2+5%C
O□を通気したクレブスヘンゼライト成製を満たしたマ
グヌス管中に懸垂し、FDピックアップを介し張力をポ
リグラフ363(日本電気三栄)上に記録した。実験は
予めアセチルコリンで血管内皮細胞依存性の弛緩反応が
観られることを確認した後、被験物質の作用を検討した
。得られたデータは101Mノルエピネフリンの弛緩反
応を100%とし、それに対する%で現し、図4に示し
た。また、EDs。値を算出し、表1に示した。
Example 4 (Effect on rabbit thoracic aorta) After killing a rabbit by exsanguination and removing the thoracic aorta by thoracotomy and cutting it into rings.
The pieces were dissected to obtain vascular strips. This is 95% O2 + 5% C
The specimen was suspended in a Magnus tube filled with Krebs-Henseleit gel through which O□ was aerated, and the tension was recorded on a Polygraph 363 (Nippon Electric Sanei) via an FD pickup. In the experiment, after confirming that a vascular endothelial cell-dependent relaxation response was observed using acetylcholine, the effects of the test substance were examined. The obtained data are expressed as % with respect to the relaxation response of 101M norepinephrine as 100%, and are shown in FIG. Also, EDs. The values were calculated and shown in Table 1.

ラット心房筋      〉3 モルモット心房筋    〉3 モルモット気管筋     0.08 モルモット回腸     〉1 家兎胸部大動脈     〉3 使用した臓器のうち気管筋を除いた臓器に対してはヘロ
デルミンは1〜3Aまで使用し50%に満たない反応し
か示さなかったのでED、。値を計算することができな
かった。また気管筋に対してはED、。値が0.081
Mと極めて小さな値を示し、ヘロデル逅ンは気管筋に対
し特異的な作用を示した。
Rat atrial muscle 〉3 Guinea pig atrial muscle 〉3 Guinea pig tracheal muscle 0.08 Guinea pig ileum 〉1 Rabbit thoracic aorta 〉3 Among the organs used, helodermin was used up to 1 to 3A, except for tracheal muscle. ED because the reaction was less than %. Could not calculate value. Also, ED for the tracheal muscles. The value is 0.081
It showed an extremely small value of M, indicating that Herodelion had a specific effect on the tracheal muscles.

実施例5(製剤例) 製剤例は以下に凍結乾燥注射剤および直腸坐剤を示すが
これに限るものではない。
Example 5 (Formulation Example) The following formulation examples include a lyophilized injection and a rectal suppository, but are not limited thereto.

製剤例1 凍結乾燥注射剤 ヘロデルミン マンニトール 00 00 mg 嗜 ヘロデルミンを発熱性物質不含の0.001%−/シポ
リオキシエチレンソルビタン脂肪酸エステルを含む注射
用蒸留水に溶かして最終濃度20μ9/−にし、更にマ
ンニトールを加える。この溶液を無菌の膜濾過系、例え
ば0.22−のマイレックスCutフィルター(ミリボ
ア社製)を介して5−ずつ各アンプルに分注し、−40
°Cで凍結させ凍結乾燥機を用い凍結乾燥し、常法によ
り無菌状態で密封した。
Formulation Example 1 Freeze-dried injection helodermin mannitol 00 00 mg Helodermin was dissolved in pyrogen-free distilled water for injection containing 0.001%-/cypolyoxyethylene sorbitan fatty acid ester to a final concentration of 20μ9/-. , and then add mannitol. This solution is dispensed through a sterile membrane filtration system, for example, a 0.22-mm Millex Cut filter (manufactured by Millibore) into each ampoule.
The mixture was frozen at °C, freeze-dried using a freeze dryer, and sealed aseptically using a conventional method.

製剤例2 直腸製剤 ヘロデルミン1004を40″Cに融解したグリセライ
ド系基剤(ライテップゾールH−15) 0.5gに5
0mMカプリン酸ナトリウムを含むように混合し、次い
で常法に従って型剤形に成形した。なお他に製剤基剤と
してはポリエチレングリコール系基剤やモノ・ジ・トリ
グリセライド系基剤等が可能であった。
Formulation Example 2 Rectal formulation Glyceride base (Litepsol H-15) prepared by melting Helodermin 1004 at 40''C 5 to 0.5g
The mixture was mixed to contain 0mM sodium caprate, and then molded into a dosage form according to a conventional method. In addition, other possible formulation bases include polyethylene glycol bases and mono-/di-triglyceride bases.

実施例6 Boa−His−3er(Bzl)−Asp(OcHe
x)−Ala−11e−Phe−Thr(Bzl)−G
tn−Gln−Tyr(Br−Z)−Set(Bzl)
−Lys(Cl−Z) −Leu−Leu−Ala−L
ys (Cl−Z) −Leu−A la −Leu−
G 1n−Lys(Cl−Z)−Tyr(Br−Z)−
Leu−AIa−Ser(Bzl)−11e−Leu−
Gl y−Set (BZ l) −Arg (M t
s) −Thr (Bz l) −5er (Bz 1
)−Pro−Pro−Pro−NHt 1.01g (
0,18mmol)  とアニソール1−の混合液にド
ライアイス−イソプロピルアルコール冷却下、無水フン
化水素10mZを加える。−2〜0℃で1時間攪拌し、
減圧tl縮する。残渣に、エーテルを加え、生じた沈澱
を濾取した。この粗結晶を、逆相カラムクロマト(TS
K−GEL 00S120T (2,15X30cm)
 ) 、溶出液アセトニトリル35.5%−0,1%ト
リフルオロ酢酸水溶液64.5%、流速8−/1lin
ニ注入し、UV210nmで溶出曲線を作威し、目的の
His−Ser−AspAla−11e−Phe−Th
r−Gln−Gln−Tyr−Ser−Lys−Leu
−Leu−A Ia−Lys−Leu−A la−Le
u−G 1n−Lys−Tyr−Leu−A 1a−5
er−11e−Leu−Gly−5er−Arg−Th
r−Ser−Pro−Pr。
Example 6 Boa-His-3er (Bzl)-Asp(OcHe
x)-Ala-11e-Phe-Thr(Bzl)-G
tn-Gln-Tyr(Br-Z)-Set(Bzl)
-Lys(Cl-Z) -Leu-Leu-Ala-L
ys (Cl-Z) -Leu-A la -Leu-
G 1n-Lys(Cl-Z)-Tyr(Br-Z)-
Leu-AIa-Ser(Bzl)-11e-Leu-
Gly-Set (BZ l) -Arg (M t
s) -Thr (Bz l) -5er (Bz 1
)-Pro-Pro-Pro-NHt 1.01g (
0.18 mmol) and anisole 1-, 10 mZ of anhydrous hydrogen fluoride is added under cooling with dry ice and isopropyl alcohol. Stir for 1 hour at -2~0℃,
Reduce the pressure by tl. Ether was added to the residue, and the resulting precipitate was collected by filtration. This crude crystal was subjected to reverse phase column chromatography (TS
K-GEL 00S120T (2,15X30cm)
), eluent acetonitrile 35.5% - 0.1% trifluoroacetic acid aqueous solution 64.5%, flow rate 8-/1 lin
The target His-Ser-AspAla-11e-Phe-Th was
r-Gln-Gln-Tyr-Ser-Lys-Leu
-Leu-A Ia-Lys-Leu-A la-Le
u-G 1n-Lys-Tyr-Leu-A 1a-5
er-11e-Leu-Gly-5er-Arg-Th
r-Ser-Pro-Pr.

Pro−NH,のピーク相当の溶出液を凍結乾燥し、目
的物102mg (15%)を得た。
The eluate corresponding to the peak of Pro-NH was freeze-dried to obtain 102 mg (15%) of the target product.

TLC; 0.27 (C: M :^、90:10:
1)[α] ”= −5,4’ (c=0.2. IM
 Ac0H)アミノ酸分析;Ash) 1.05(1)
、 Thr 1.95(2)Set 4.47(5)、
 Gln 3.09(3)Gly 1.03(1)、 
Ala 4.IM4)lie 1.89(2)、 Le
u 6.46(6)Tyr 2.10(2)、 Phe
 O,92(1)Lys 3.04(3)、 His 
O,91(1)八rg  1.04(1)、  Pro
  2.94(3)実施例7 30C−Hts−3er 21 As OcHex −^1a−11e−Phe−Thr Boc−Lys (Cl−Z)−Leu−Leu−Al
a−Lys (Cl−Z) −LeuA Ia−Leu
−Gin−Lys (Cl−Z) −Tyr (Or−
Z)−Leu−Al a−3er(Bz 1) −11
e−Leu−Gly−Set (Bz 1)−Arg 
(Mts) −Thr (Bz 1)−Set(Bzl
)−Pro−Pro−Pro−NHz 3.OOg  
(0,76mmol)を、O″C冷却下トリフルオロ酢
酸30mZに溶かし、3時間撹拌した。反応後、減圧′
a縮し、残渣にエーテルを加え、生じた沈澱を濾取した
。得られた沈澱をN−メチルピロリドン84m1に)容
かし、0℃冷却下、N−メチルモルホリンでp117に
調整した。この溶液に、Boc−His−3er(Bz
l)−Asp(OcHex)−Ala−11e−Phe
−Thr (Bz 1)−Gin−G In−Tyr 
(Br−Z)−3er(Bzl)−0H2,12g(1
1,5mmol) 、Hoobto、28g(1,74
mmol)を加え、更に0“C冷却下WSC・HCl 
0.40g(2,10mmol)を加え、室温で5日間
撹拌した0反応後、減圧濃縮し、残渣に5%重曹水を加
え、生じた沈澱物を水で洗浄した。減圧乾燥後、この沈
澱物を5ephadex LFI−20のカラムクロマ
ト(3,2X96cm)にアプライし、溶出溶媒DMF
を用いるカラムクロマトグラフィーにより精製した。3
gずつ分画し、67−76本目を集め、減圧濃縮し、エ
ーテルを加え、析出した沈澱を濾取し、目的のBoc−
)1is−Set(Bzl)−^sp (OcHex)
−Ala−11e−Phe−Thr (Bz l) −
G In−G In−Tyr (Br−Z) −5er
(Bzl)−Lys(Cl−Z)−Leu−Leu−^
1a−Lys(Cl−Z)−Leu−^1a−Leu−
Gln−Lys(Cl−Z)−Tyr(Br−Z)−L
eu−Ala−Ser(Bzl)−I 1e−Leu−
Gly−Set (Bz 1) −Arg (Mts)
 −Thr (Bz 1)−Set(Bzl)−Pro
−Pro−Pro−NHz 3.16g(72,6%)
を得た。
TLC; 0.27 (C: M:^, 90:10:
1) [α] ”= -5,4' (c=0.2. IM
Ac0H) Amino acid analysis; Ash) 1.05 (1)
, Thr 1.95 (2) Set 4.47 (5),
Gln 3.09 (3) Gly 1.03 (1),
Ala4. IM4)lie 1.89(2), Le
u 6.46 (6) Tyr 2.10 (2), Phe
O,92(1)Lys 3.04(3),His
O,91(1)8rg 1.04(1), Pro
2.94 (3) Example 7 30C-Hts-3er 21 As OcHex -^1a-11e-Phe-Thr Boc-Lys (Cl-Z)-Leu-Leu-Al
a-Lys (Cl-Z) -LeuA Ia-Leu
-Gin-Lys (Cl-Z) -Tyr (Or-
Z)-Leu-Al a-3er(Bz 1)-11
e-Leu-Gly-Set (Bz 1)-Arg
(Mts) -Thr (Bz 1) -Set(Bzl
)-Pro-Pro-Pro-NHz 3. OOg
(0.76 mmol) was dissolved in 30 mZ of trifluoroacetic acid under cooling at O''C and stirred for 3 hours. After the reaction, reduced pressure
After condensation, ether was added to the residue, and the resulting precipitate was collected by filtration. The obtained precipitate was poured into 84 ml of N-methylpyrrolidone and adjusted to pH 117 with N-methylmorpholine while cooling at 0°C. Boc-His-3er (Bz
l)-Asp(OcHex)-Ala-11e-Phe
-Thr (Bz 1)-Gin-G In-Tyr
(Br-Z)-3er(Bzl)-0H2, 12g (1
1,5 mmol), Hoobto, 28 g (1,74
mmol) and further cooled at 0"C with WSC/HCl
After 0.40 g (2.10 mmol) was added and stirred at room temperature for 5 days, the reaction mixture was concentrated under reduced pressure. 5% aqueous sodium bicarbonate was added to the residue, and the resulting precipitate was washed with water. After drying under reduced pressure, this precipitate was applied to a 5ephadex LFI-20 column chromatograph (3.2 x 96 cm), and the elution solvent was DMF.
It was purified by column chromatography using . 3
The 67th to 76th fractions were collected, concentrated under reduced pressure, ether was added, the precipitate was collected by filtration, and the desired Boc-
)1is-Set(Bzl)-^sp (OcHex)
-Ala-11e-Phe-Thr (Bz l) -
G In-G In-Tyr (Br-Z) -5er
(Bzl)-Lys(Cl-Z)-Leu-Leu-^
1a-Lys(Cl-Z)-Leu-^1a-Leu-
Gln-Lys(Cl-Z)-Tyr(Br-Z)-L
eu-Ala-Ser(Bzl)-I 1e-Leu-
Gly-Set (Bz 1) -Arg (Mts)
-Thr (Bz 1) -Set (Bzl) -Pro
-Pro-Pro-NHz 3.16g (72.6%)
I got it.

融点:268°C(分解) TLC;0.79 (B:A:Py:W、 90: 6
 :20:24)〔α〕”−−8,0’ (c=1.0
+ DMSO)元素分析値Ctss)I4oJnJ7t
ClJrzS l 14EIzOとしてHN 理論値(%)  56.85 6.81 10.93実
測値(%)  56,73 6.22 10.82アξ
ノ酸分析;^sp 1.00(1)、 Thr 1.8
B(2)Set 3.97(5)、  Gin 3.0
9(3)Gly 1.IHl)、  Ala 4.27
(4)lio 1.89(2)、  Leu 6.34
(6)Tyr 2.05(2)、  Phe O,99
(1)Lys 3.15(3)、 I(is 0.88
(1)Arg 1.14(1)、  Pro、3.24
(3)以下、本発明の保護ヘロデル果ンの製法に用いた
原料ペプチドの合成例を参考例として示す。
Melting point: 268°C (decomposition) TLC; 0.79 (B:A:Py:W, 90:6
:20:24) [α]"--8,0' (c=1.0
+ DMSO) Elemental analysis value Ctss) I4oJnJ7t
HN as ClJrzS l 14EIzO Theoretical value (%) 56.85 6.81 10.93 Actual value (%) 56,73 6.22 10.82Aξ
Noic acid analysis; ^sp 1.00 (1), Thr 1.8
B (2) Set 3.97 (5), Gin 3.0
9(3)Gly 1. IHL), Ala 4.27
(4) lio 1.89 (2), Leu 6.34
(6) Tyr 2.05 (2), Phe O, 99
(1) Lys 3.15(3), I(is 0.88
(1) Arg 1.14(1), Pro, 3.24
(3) Hereinafter, an example of synthesis of the raw material peptide used in the method for producing protected Herodel fruit of the present invention will be shown as a reference example.

参考例1 Z−Pro−Pro−OHの ゛ Fl−Pro−OH5,18g (45,Osmol)
を水20−に溶かし、0゛C冷却下トリエチルアミン6
.3 m7 (45ms+ol)を加えた。この混合液
にZ−Pro−OSu 10.4g(30,Osmol
 )のジオキサンを容液40−を加え、室温で一晩撹拌
した。反応後、この反応液にトリエチルアミンを加え、
pH9に調整した後、酢酸エチル100−で洗浄した。
Reference example 1 Z-Pro-Pro-OH ゛Fl-Pro-OH 5,18 g (45, Osmol)
Dissolved in 20°C of water and diluted with triethylamine 6°C under cooling at 0°C.
.. 3 m7 (45ms+ol) was added. 10.4 g of Z-Pro-OSu (30, Osmol
) of dioxane was added thereto and stirred overnight at room temperature. After the reaction, add triethylamine to this reaction solution,
After adjusting the pH to 9, it was washed with 100% of ethyl acetate.

水相をO′C冷却冷却場濃塩酸)IIに調整した後、析
出した沈澱物を濾取し、水で洗浄した。減圧乾燥後、メ
タノール−エーテルで再沈澱し、目的のZ−Pro−P
ro−OH6,85g (65,9%)を得た。
After adjusting the aqueous phase to concentrated hydrochloric acid (II) in an O'C cooling field, the deposited precipitate was collected by filtration and washed with water. After drying under reduced pressure, reprecipitation was performed with methanol-ether to obtain the desired Z-Pro-P.
6.85 g (65.9%) of ro-OH was obtained.

融点;169−70℃ TLC;0.40 (COMMA、 90:10: 1
 )(α) ”=96.6’  (c =1.Or M
eoll)元素分析値 C+*HzJzOs・N20と
してHN 理論値(%)  62.57 6.40 7.84実測
値(%)  62.42 6.40 8.09参考例2 Z−Pro−Pro−Pro−NHz  の 1゛告Z
−Pro−Pro−OHL、73g (5,OOmmo
+) 、1t−Pro−NHIo、80g (7,01
mmol)及び、HOBt 0.92g (6,01+
mmol)を、THF 15@7−DI’lF 25m
7−DMSo 20 m7に溶かし、O″C冷却下DC
C1,50g (7,25mmol)を加え、低温室(
+4°C)で−晩撹拌した。反応後、析出した沈澱物を
濾取し、減圧濃縮後、残渣をCthCh150−に溶か
し、5%重曹水、水の順で洗浄し、無水硫酸ナトリウム
で乾燥した。減圧濃縮後、残渣にエーテル−石油エーテ
ル(1: 1)を加え、生じた沈澱を濾取し、目的のZ
−Pro−Pro−Pr。
Melting point: 169-70°C TLC: 0.40 (COMMA, 90:10:1
)(α) ”=96.6' (c=1.Or M
eoll) Elemental analysis value HN as C+*HzJzOs・N20 Theoretical value (%) 62.57 6.40 7.84 Actual value (%) 62.42 6.40 8.09 Reference example 2 Z-Pro-Pro-Pro -NHZ 1゛Notification Z
-Pro-Pro-OHL, 73g (5,OOmmo
+), 1t-Pro-NHIo, 80g (7,01
mmol) and HOBt 0.92g (6,01+
mmol), THF 15@7-DI'IF 25m
7-DMSo Dissolved in 20 m7 DC under cooling at O''C.
Add 1.50 g (7.25 mmol) of C and place it in a cold room (
+4°C) overnight. After the reaction, the deposited precipitate was collected by filtration, concentrated under reduced pressure, and the residue was dissolved in CthCh150-, washed with 5% sodium bicarbonate solution and water in that order, and dried over anhydrous sodium sulfate. After concentration under reduced pressure, ether-petroleum ether (1:1) was added to the residue, the resulting precipitate was collected by filtration, and the desired Z
-Pro-Pro-Pr.

−Nllz 2.08g (94,0%)を得た。-Nllz 2.08g (94.0%) was obtained.

融点;188−89°C TLC: 0.31 (C: M :^、90:10:
1)(α) ”= −16,0”  (c=1.0. 
MeOH)元素分析値 CzJa。N40.としてCH
N 理論値(%)  62.40 7.21 12.36実
測値(%)  62.43 6.83 12.66参考
例3 Boc−Thr(Bzl −5et(Bzl)−0Pa
cの ゛1文献記載(Ger、0ffen、DE342
8942 )の方法により調整したBoc−Set(B
zl) −0Pac 8.27g (20,0+III
ol)をアセトニトリル100−にン容かし、0°C冷
却下、トシル酸−水和物19.0g (100,Osm
ol)を加え、8時間撹拌した。反応後、減圧濃縮し、
残渣にエーテルを加え、生じた沈澱を濾取した。
Melting point: 188-89°C TLC: 0.31 (C: M:^, 90:10:
1) (α) ”= −16,0” (c=1.0.
MeOH) Elemental analysis value CzJa. N40. as CH
N Theoretical value (%) 62.40 7.21 12.36 Actual value (%) 62.43 6.83 12.66 Reference example 3 Boc-Thr (Bzl -5et (Bzl) -0Pa
c.1 Literature description (Ger, Offen, DE342
Boc-Set (B
zl) -0Pac 8.27g (20,0+III
19.0 g of tosylic acid hydrate (100,Osm
ol) was added and stirred for 8 hours. After the reaction, concentrate under reduced pressure,
Ether was added to the residue, and the resulting precipitate was collected by filtration.

得られた沈澱をDMF 100 aZに溶かし、−15
°C冷却下、N−メチルモルホリンでpH7に調整した
The obtained precipitate was dissolved in DMF 100 aZ, -15
The pH was adjusted to 7 with N-methylmorpholine while cooling at °C.

一方、Boc−Thr(Bzl)−0H7,42g (
24,Osmol)、)IOB t3.68g (24
,0mmol)をDMF 10m7−THF 50−の
混合液に溶かし、0゛C冷却下DCC5,94g (2
8,8m1iol)のTHF溶液20@lを加え、0°
C冷却下30分間撹拌した。この溶液を前記の溶液へ加
え、−15°Cで1時間、0°Cで2時間、低温室(+
4°C)で−晩撹拌した。反応後、析出した沈澱物を濾
取し、減圧濃縮後、残渣を酢酸エチル300−に溶かし
、10%クエン酸水溶液、5%重曹水、水の順で洗浄し
、無水硫酸ナトリウムで乾燥した。減圧濃縮後、残渣に
エーテルを加え、生じた沈澱を濾取し、目的のBoc−
Thr(Bzl)  5er(Bzl)−0Pac9.
64g(79,4%)を得た。
On the other hand, Boc-Thr(Bzl)-0H7,42g (
24, Osmol),) IOB t3.68g (24
, 0 mmol) was dissolved in a mixed solution of 10 m of DMF and 50 mm of THF, and 5.94 g of DCC (2
Add 20@l of THF solution of 8.8ml iol) and
The mixture was stirred for 30 minutes under cooling. This solution was added to the previous solution and incubated at -15°C for 1 hour and at 0°C for 2 hours in a cold room (+
Stir overnight at 4°C. After the reaction, the precipitate precipitated was collected by filtration, concentrated under reduced pressure, and the residue was dissolved in 300% ethyl acetate, washed with 10% aqueous citric acid, 5% aqueous sodium bicarbonate, and water in this order, and dried over anhydrous sodium sulfate. After concentration under reduced pressure, ether was added to the residue, the resulting precipitate was collected by filtration, and the desired Boc-
Thr(Bzl) 5er(Bzl)-0Pac9.
64 g (79.4%) were obtained.

融点、100’C TLC;0.76 (C:M、9 i 1)(α) ”
=+7.7’  (c=1.0. DMF)元素分析値
 C5aHa。N*011/ 58gOとしてHN 理論値(%”)  67.08 6.68 4.74実
測値(%)  67.13 6.69 4.61参考例
4 Boa−Ar −Mts −Thr Bzl −5er
 Bzl −0PacのBoc−Thr(Bzl)−S
er(Bzl)−0Pac 6.04g(9,99nv
+ol)を、0°C冷却下4NHC1−ジオキサン50
@lに溶かし、2時間撹拌した後、エーテルを加え、生
じた沈澱を濾取した。得られた粉末をDMF 20dに
溶かし、0℃冷却下N−メチルモルホリン1.05ad
 (10,3+wmol)を加えpo’yに調整した。
Melting point, 100'C TLC; 0.76 (C:M, 9 i 1) (α)''
=+7.7' (c=1.0. DMF) Elemental analysis value C5aHa. N*011/ 58 HN as gO Theoretical value (%") 67.08 6.68 4.74 Actual value (%) 67.13 6.69 4.61 Reference example 4 Boa-Ar -Mts -Thr Bzl -5er
Bzl-0Pac's Boc-Thr(Bzl)-S
er(Bzl)-0Pac 6.04g (9,99nv
+ol) in 4N HCl-dioxane 50°C under cooling at 0°C.
After dissolving in @l and stirring for 2 hours, ether was added and the resulting precipitate was collected by filtration. The obtained powder was dissolved in 20d of DMF, and 1.05ad of N-methylmorpholine was added under cooling at 0°C.
(10,3+wmol) was added to adjust to po'y.

この混合液に、Boc−Arg(Mts)−OR−Ac
OEt ・1 / 58z06.24g (12,0+
+■ol)、HOBtl、84g (12,0+u+o
n)のD?IP10d −THF35−の混合溶液、D
CC2,48g (12,0gaol)のTHF30−
の溶液を加え、低温室(+4°C)で−晩撹拌した。反
応後、析出した沈澱物を濾取し、減圧濃縮後、残渣を酢
酸エチル300−に溶かし、10%クエン酸水溶液、5
%重曹水、水の順で洗浄し、無水硫酸ナトリウムで乾燥
した。減圧濃縮後、残渣にエーテル加え、生じた沈澱を
濾取し、目的のBoc−Arg(Mts)−Thr(B
zl)Set (Bzl)−0Pac 8.93g (
94,8%)を得た。
Boc-Arg(Mts)-OR-Ac
OEt ・1 / 58z06.24g (12,0+
+■ol), HOBtl, 84g (12,0+u+o
D of n)? Mixed solution of IP10d-THF35-, D
CC2,48g (12,0gaol) of THF30-
solution was added and stirred overnight in a cold room (+4°C). After the reaction, the precipitate precipitated was collected by filtration and concentrated under reduced pressure.
% sodium bicarbonate solution and then water, and dried over anhydrous sodium sulfate. After concentration under reduced pressure, ether was added to the residue, the resulting precipitate was collected by filtration, and the desired Boc-Arg(Mts)-Thr(B
zl)Set (Bzl)-0Pac 8.93g (
94.8%) was obtained.

融点ニア0−2°C TLC;0.59 (C:M、9  :  1)(α)
  ”=−1,2° (c =1.0.  MeOH)
元素分析値 C4,Hi、tNiO+ +S・3 / 
41(!0としてIIN 理論値(%)61.36 6.63 8.85実測値(
%)  61,52 6.69 8.78アミノ酸分析
; Thr O,98(1)  Set 0.93(1
)Arg 1.08(1) 参考例5 Boc−Arg(Mts)−Thr(Bzl)−3et
(Bzl)−0Pac 4.40g (4,67mmo
l)を、0℃冷却下4N塩酸−ジオキサン溶液35m1
に溶かし、2時間攪拌した後、エーテルを加え、生じた
沈澱を濾取した。得られた粉末をDMF 30WL1−
THF to−の混合液に溶かし、0℃冷却下N−メチ
ルモルホリンを加えpH7に調整した。この混合液に、
Boc−Set(Bzl)−0t11.65g (5,
59mmol)、HOBt 0.86g (5,62n
+mol)を加え、更に、WSC−HCl 1.29g
 (6,73問o1)を加え、0℃冷却下1時間、低温
室(+4℃)で−晩撹拌した0反応後、減圧tM縮し、
残渣に10%クエン酸水溶液を加え、生じた沈澱を濾取
し、5%重曹水、水の順で洗浄した。減圧乾燥後、メタ
ノール−エーテル−石油エーテルで再沈澱し、目的のB
oc−Ser(Bzl) =Arg(Mts)−Thr
(Bzl)−5et(Bzl)−OPac 5.04g
 (96,3%)を得た。
Melting point near 0-2°C TLC; 0.59 (C:M, 9:1) (α)
”=-1,2° (c=1.0.MeOH)
Elemental analysis value C4, Hi, tNiO+ +S・3 /
41 (IIN as !0 Theoretical value (%) 61.36 6.63 8.85 Actual value (
%) 61,52 6.69 8.78 Amino acid analysis; Thr O,98(1) Set 0.93(1
)Arg 1.08(1) Reference Example 5 Boc-Arg(Mts)-Thr(Bzl)-3et
(Bzl)-0Pac 4.40g (4.67mmo
l) in 35 ml of 4N hydrochloric acid-dioxane solution under cooling at 0°C.
After stirring for 2 hours, ether was added and the resulting precipitate was collected by filtration. The obtained powder was mixed with DMF 30WL1-
The mixture was dissolved in a mixed solution of THF to-, and the pH was adjusted to 7 by adding N-methylmorpholine while cooling at 0°C. In this mixture,
Boc-Set (Bzl)-0t11.65g (5,
59mmol), HOBt 0.86g (5,62n
+ mol) and further 1.29 g of WSC-HCl
(Question 6, 73 o1) was added and stirred for 1 hour in a cold room (+4°C) for 1 hour under cooling at 0°C, followed by condensation under reduced pressure tM,
A 10% aqueous citric acid solution was added to the residue, and the resulting precipitate was collected by filtration and washed successively with 5% aqueous sodium bicarbonate and water. After drying under reduced pressure, it is reprecipitated with methanol-ether-petroleum ether to obtain the desired B.
oc-Ser(Bzl)=Arg(Mts)-Thr
(Bzl)-5et(Bzl)-OPac 5.04g
(96.3%) was obtained.

融点;84−6℃ TLC;0.80 (C:M、9 : 1)〔α) ”
−−4,6’  (c =1.0. DMF)元素分析
値 C*J1.zNiO□S・3 / 4 utoとし
てON 理論値(%)  61,36 6.63 8.85実測
値(%)  61,52 6.69 8.78アξノ酸
分析;Thr 1.01(1)  Set 1.89(
2)Arg 1.10(1) 参考例6 Boc−3et(Bzl)−Arg(Mts)−Thr
(Bzl)−Ser(Bzl)−0Pac 5.OOg
 (4,04ssol)を95%酢酸水溶液5〇−に溶
かし、活性化した亜鉛末を7.92g (1211Im
ol)を加え、室温で6.5時間激しく攪拌した。亜鉛
末を濾取した後、酢酸を減圧留去し、残渣に、酢酸エチ
ル200117を加え、10%クエン酸水溶液、飽和食
塩水の順で洗浄し、無水硫酸ナトリウムで乾燥した。減
圧濃縮後、残渣にエーテル−石油エーテルを加え、生じ
た沈澱を濾取し、目的のBoc−3et(Bzl)−A
rg(Mts)−Thr(Bzl)−5et(Bzl)
−OH4,07g (100%)を得た。
Melting point: 84-6°C TLC: 0.80 (C:M, 9:1) [α)”
--4,6' (c = 1.0. DMF) Elemental analysis value C*J1. zNiO□S・3/4 ON as auto Theoretical value (%) 61,36 6.63 8.85 Actual value (%) 61,52 6.69 8.78 Anoic acid analysis; Thr 1.01 (1 ) Set 1.89(
2) Arg 1.10(1) Reference Example 6 Boc-3et(Bzl)-Arg(Mts)-Thr
(Bzl)-Ser(Bzl)-0Pac 5. OOg
(4,04ssol) was dissolved in 95% acetic acid aqueous solution, and 7.92g of activated zinc powder (1211Im
ol) was added and stirred vigorously at room temperature for 6.5 hours. After filtering the zinc dust, acetic acid was distilled off under reduced pressure, and ethyl acetate 200117 was added to the residue, which was washed with a 10% aqueous citric acid solution and saturated brine in that order, and dried over anhydrous sodium sulfate. After concentration under reduced pressure, ether-petroleum ether was added to the residue, the resulting precipitate was collected by filtration, and the desired Boc-3et (Bzl)-A was obtained.
rg(Mts)-Thr(Bzl)-5et(Bzl)
-OH 4.07g (100%) was obtained.

融点;81−85℃ TLC;0.53 (C:M、4 : 1)〔α) ”
 −+ 12.2 ”  (c =1−0+ DMF)
元素分析値 Cs+HbJLtO□S・7 / 3 t
t、oとしてON 理論値(%’)  58.66 6.92 9.39実
測値(%)  5B、69 6,63 9.84参考例
7 Boc−Set(Bzl)−^r (Mts)−Thr
(Bzl)−3et(Bzl)−Pr。
Melting point: 81-85°C TLC: 0.53 (C:M, 4:1) [α)”
−+ 12.2” (c = 1-0+ DMF)
Elemental analysis value Cs+HbJLtO□S・7/3t
ON as t and o Theoretical value (%') 58.66 6.92 9.39 Actual value (%) 5B, 69 6,63 9.84 Reference example 7 Boc-Set (Bzl)-^r (Mts)- Thr
(Bzl)-3et(Bzl)-Pr.

2二皇1虹期宴44遣 Z−Pro−Pro−Pro−NHx 2.02g (
4,56a+a+ol)を25%臭化水素−酢酸15−
に溶かし、0℃で4時間攪拌した後、エーテルを加え、
生じた沈澱を濾取した。得られた粉末をDMF 60−
に溶かし、0℃冷却下N−メチルモルホリンを加えpH
7に調整した。この混合液に、Boc−Set(Bzt
)−Arg(Mts)−Thr(Bzl)−Set(B
zl)−0H3,80g  (3,79ssol)  
、!(OBtO,71g (4,64m5+ol)を加
え、更に−SC・tlcl 1.05g(5,48ss
ol)を加え、低温室(+4℃)で−晩攪拌した0反応
後、減圧濃縮し、残渣に10%クエン酸水溶液を加え、
生じた沈澱を濾取し、5%重曹水、水の順で洗浄した。
22 Emperors 1 Rainbow Festival 44 Z-Pro-Pro-Pro-NHx 2.02g (
4,56a+a+ol) to 25% hydrogen bromide-acetic acid 15-
After stirring at 0°C for 4 hours, ether was added,
The resulting precipitate was collected by filtration. The obtained powder was mixed with DMF 60-
Add N-methylmorpholine under cooling to 0°C to adjust the pH.
Adjusted to 7. Boc-Set (Bzt
)-Arg(Mts)-Thr(Bzl)-Set(B
zl)-0H3,80g (3,79ssol)
,! (OBtO, 71g (4,64m5+ol) was added, and -SC・tlcl 1.05g (5,48ss
After the reaction, the mixture was stirred overnight in a cold room (+4°C), concentrated under reduced pressure, and a 10% aqueous citric acid solution was added to the residue.
The resulting precipitate was collected by filtration and washed successively with 5% sodium bicarbonate solution and water.

減圧乾燥後、DMF−酢酸エチル−エーテルで再沈澱し
、目的のBoc−3et(Bzl)−Arg(Mts)
−Thr(Bzl)−3et(Bzl)−Pro−Pr
o−Pro−NHx 5.21g (88,4%)を得
た。
After drying under reduced pressure, reprecipitation was performed with DMF-ethyl acetate-ether to obtain the desired Boc-3et (Bzl)-Arg (Mts).
-Thr(Bzl)-3et(Bzl)-Pro-Pr
5.21 g (88.4%) of o-Pro-NHx was obtained.

融点:101−6℃ TLC;0.83 (C:M、 4 : 1)〔α〕■
寓−34,9” (cモ1.0. DJ’lF)元素分
析値 C1HsvN++0+4S・4HtOとしてCM
      N 理論値(%)  58.09 7.16 11.29実
測値(%)  58,37 6.7?  10.81ア
電ノ酸分析;Thr 1.05(1)  Set 1.
96(2)Arg 1.05(1)  Pro 2.9
2(3)参考例8 Boc−Leu−Gl−OPacの7゛6TosOH−
H−Gly−OPac  95.Og  (0,26s
sol)  をDMF350−に溶かし、−15℃冷却
下、N−メチルモルホリンでpH1に調整した。一方、
Boc−Leu−OR・H2O64,4g  (0,2
6ssol) 、)IOBt 43.5g (0,28
11IIol)をDMF 100 @7−TF!F 1
00−の混合液に溶かし、O℃冷却下DCC64,4g
(0,31ssol)のTHFHF溶液200脊Zえ、
0℃冷却下45分間攪拌した。
Melting point: 101-6°C TLC; 0.83 (C:M, 4:1) [α]■
-34,9" (cmo1.0. DJ'lF) Elemental analysis value CM as C1HsvN++0+4S・4HtO
N Theoretical value (%) 58.09 7.16 11.29 Actual value (%) 58,37 6.7? 10.81 Electronoic acid analysis; Thr 1.05 (1) Set 1.
96(2) Arg 1.05(1) Pro 2.9
2(3) Reference Example 8 7゛6TosOH- of Boc-Leu-Gl-OPac
H-Gly-OPac 95. Og (0,26s
sol) was dissolved in DMF350-, and the pH was adjusted to 1 with N-methylmorpholine while cooling at -15°C. on the other hand,
Boc-Leu-OR・H2O64,4g (0,2
6ssol) ,)IOBt 43.5g (0,28
11IIol) to DMF 100 @7-TF! F1
64.4 g of DCC dissolved in a mixed solution of
(0,31 ssol) of THFHF solution 200 times,
The mixture was stirred for 45 minutes while cooling at 0°C.

この溶液を前記の溶液へ加え、−15℃で1時間、0℃
で2時間、低温室(+4℃)で−晩攪拌した。反応後、
析出した沈澱物を濾取し、減圧濃縮後、残渣を酢酸エチ
ル500−に溶かし、10%クエン酸水溶液、5%重曹
水、飽和食塩水の順で洗浄し、無水硫酸ナトリウムで乾
燥した。減圧濃縮後、残渣に石油エーテルを加え、生じ
た沈澱を濾取し、目的のBoc−Lea−Guy−OP
ac 87.1g(83,0%)を得た。
Add this solution to the above solution and hold at -15°C for 1 hour at 0°C.
The mixture was stirred for 2 hours at room temperature and overnight in a cold room (+4°C). After the reaction,
The precipitate was collected by filtration, concentrated under reduced pressure, and the residue was dissolved in 500% ethyl acetate, washed successively with 10% aqueous citric acid, 5% aqueous sodium bicarbonate, and saturated brine, and dried over anhydrous sodium sulfate. After concentration under reduced pressure, petroleum ether was added to the residue, and the resulting precipitate was collected by filtration to obtain the desired Boc-Lea-Guy-OP.
87.1 g (83.0%) of ac was obtained.

融点;107℃ TLC:0.67 (C:M、9 : 1)〔α) ”
=−28,6@(c =1.0. MeOH)元素分析
値 C!It13゜N!0゜としてCHN 理論値(%)  62.05 7.44 6.89実測
値(%)  62.06 7.51 6.76参考例9 Boc−Tie−Leu−Gl −0Pacの Boa
−Lea−Gly−OPac 15.Og (37,0
wmol)を、0℃冷却下4N lIcl−ジオキサン
1851117に溶かし、1時間攪拌した後、エーテル
を加え、生じた沈澱を濾取した。得られた粉末をDMF
 70mj−THF50−の混合液に溶かし、0℃冷却
下N−メチルモルホリンでpH7に調整した。一方、B
oc−I 1eOH・1/2H!010.7g (44
,5mmol) 、HOBt 6.81g(44,4+
+nol)をDMF 20WLl−TFIP 30−の
混合液に溶かし、O℃冷却下DCC11,Og (53
,2+wmol)のTI(F溶液30m1を加え、O℃
冷却下1時間攪拌した。
Melting point: 107°C TLC: 0.67 (C:M, 9:1) [α)”
=-28,6 @ (c = 1.0. MeOH) elemental analysis value C! It13°N! CHN as 0° Theoretical value (%) 62.05 7.44 6.89 Actual value (%) 62.06 7.51 6.76 Reference example 9 Boa of Boc-Tie-Leu-Gl-0Pac
-Lea-Gly-OPac 15. Og (37,0
wmol) was dissolved in 4N 1ICl-dioxane 1851117 under cooling at 0°C, stirred for 1 hour, ether was added, and the resulting precipitate was collected by filtration. The obtained powder is DMF
It was dissolved in a mixed solution of 70mj-THF50-, and the pH was adjusted to 7 with N-methylmorpholine while cooling at 0°C. On the other hand, B
oc-I 1eOH・1/2H! 010.7g (44
,5 mmol), HOBt 6.81 g (44,4+
+nol) was dissolved in a mixed solution of DMF 20WLl-TFIP 30-, and DCC11,Og (53
, 2 + wmol) of TI (F solution) was added, and the mixture was heated at O℃.
The mixture was stirred for 1 hour under cooling.

この溶液を前記の溶液へ加え、低温室(+4℃)で−晩
撹拌した0反応後、析出した沈澱物を濾取し、減圧濃縮
後、残渣を酢酸エチル250−に溶かし、10%クエン
酸水溶液、5%重曹水、飽和食塩水の順で洗浄し、無水
硫酸ナトリウムで乾燥した。減圧濃縮後、残渣にn−ヘ
キサンを加え、生じた沈澱を濾取し、目的のBoc−1
1e−Leu−Gly−OPac 19.1g (99
,9%)を得た。
This solution was added to the above solution and stirred overnight in a cold room (+4°C). After the reaction, the precipitate precipitated was collected by filtration and concentrated under reduced pressure. It was washed successively with an aqueous solution, 5% sodium bicarbonate solution, and saturated brine, and dried over anhydrous sodium sulfate. After concentration under reduced pressure, n-hexane was added to the residue, the resulting precipitate was collected by filtration, and the desired Boc-1
1e-Leu-Gly-OPac 19.1g (99
, 9%).

融点i  137−8℃ TLC;0.65 (C:M、9 : 1)〔α) ”
= −25,4@(c −1,0,DMF)元素分析値
 Ct7H□N307・1/2ntoとしてCHN 理論値(%)  61.34 8,01 7.95実測
値(%”)  61.31 7,77 7.98参考例
10 Boc−Ser(Bzl)−11e−Leu−Gl−O
PacのBoc−11e−Leu−Gly−OPac 
53.4g (0,1011ol)を、O℃冷却下4N
 HCl−ジオキサン250 m7に溶かし、3時間撹
拌した後、エーテルを加え、生じた沈澱を濾取した。得
られた粉末をDMF 110 af−THF15−の混
合液に溶かし、O℃冷却下N−メチルモルホリンでpH
7に調整した。一方、Boc−5et(Bzl)−08
35,4g (0,12mol)、HOBt 18.4
g (0,12mmol)をDMF 100 I17に
溶かし、0°C冷却下−SC・lIc127.6g (
0,14mol)のTHF溶液30−を加え、O″C冷
却下0.5時間撹拌した。この溶液を前記の溶液へ加え
、0°C冷却下1.5時間、低温室(+4℃)で−晩撹
拌した0反応後、減圧濃縮後、残渣に5%重曹水を加え
て沈澱化し、10%クエン酸水溶液、飽和食塩水の順で
洗浄した。
Melting point i 137-8℃ TLC; 0.65 (C:M, 9:1) [α)”
= -25,4@(c -1,0,DMF) Elemental analysis value CHN as Ct7H□N307・1/2nto Theoretical value (%) 61.34 8,01 7.95 Actual value (%") 61.31 7,77 7.98 Reference Example 10 Boc-Ser(Bzl)-11e-Leu-Gl-O
Pac's Boc-11e-Leu-Gly-OPac
53.4g (0,1011ol) was heated at 4N under cooling at 0°C.
After dissolving in 250 m7 of HCl-dioxane and stirring for 3 hours, ether was added and the resulting precipitate was collected by filtration. The obtained powder was dissolved in a mixture of DMF 110 af-THF15-, and the pH was adjusted with N-methylmorpholine while cooling at 0°C.
Adjusted to 7. On the other hand, Boc-5et (Bzl)-08
35.4g (0.12mol), HOBt 18.4
Dissolve g (0.12 mmol) in DMF 100 I17 and cool at 0°C -SC・lIc127.6 g (
A THF solution (30-0.14 mol) of After the reaction was stirred overnight and concentrated under reduced pressure, 5% aqueous sodium bicarbonate was added to the residue to precipitate it, which was then washed with a 10% aqueous citric acid solution and saturated brine.

減圧乾燥後゛、DMF−エーテル(1: 5)で再沈澱
し、目的のBoc−Set(Bzl)−11e−Leu
−Gly−OPac69.7g (100%)を得た。
After drying under reduced pressure, it was reprecipitated with DMF-ether (1:5) to obtain the desired Boc-Set (Bzl)-11e-Leu.
-Gly-OPac 69.7g (100%) was obtained.

融点;  137−8°C TLC;0.81 (C:M、9 : 1)〔α) ”
=−12,2”  (c −1,0,DMF)元素分析
値 C5rHs!N40qとしてCON 理論値(%)  63.77 7,52 8.04実測
値(%)  63.53 7,53 8.05参考例1
1 Boc−Ala−3er(Bzl −11e−Leu−
Gl−OPacのBoc−5et(Bzl)−11e−
Leu−Gly−OPac 10.5g(15,0nv
ol)を、0℃冷却下50%トリフルオロ酢酸の塩化メ
チレン溶液60−に溶かし、3時間撹拌した後、エーテ
ルを加え、生じた沈澱を濾取した。
Melting point; 137-8°C TLC; 0.81 (C:M, 9:1) [α)”
=-12,2" (c -1,0,DMF) Elemental analysis value CON as C5rHs!N40q Theoretical value (%) 63.77 7,52 8.04 Actual value (%) 63.53 7,53 8. 05 Reference example 1
1 Boc-Ala-3er (Bzl-11e-Leu-
Gl-OPac Boc-5et (Bzl)-11e-
Leu-Gly-OPac 10.5g (15,0nv
ol) was dissolved in a 60% solution of 50% trifluoroacetic acid in methylene chloride while cooling at 0°C, and after stirring for 3 hours, ether was added and the resulting precipitate was collected by filtration.

得られた粉末をDMF 50d−THP 60−の混合
液に溶かし、0°C冷却冷却−N−メチルホリンでpH
7に調整した。この混合液に、Boa−Ala−OH3
,12g (16,5n+s+ol)、HOBt 2.
53g (16,5a+mol)のDMF5 mA −
THF 20−の混合液を加え、更に、tisc・HC
l 3.45g (18,0011101)のDMF 
5 at−THF 20−の混合液を加え、0℃で1時
間、低温室(+4℃)で−晩撹拌した0反応後、減圧濃
縮し、残渣に5%クエン酸水溶液を加え、生じた沈澱を
濾取し、5%重曹水、水の順で洗浄し、目的のBoc−
Ala−Ser(Bzl)−11e−Leu−Gly−
OPac 10.8g(93,5mmol)を得た。
The obtained powder was dissolved in a mixture of DMF 50d-THP 60- and cooled at 0°C. The pH was adjusted with N-methylphorine.
Adjusted to 7. Add Boa-Ala-OH3 to this mixture.
, 12g (16,5n+s+ol), HOBt 2.
53g (16,5a+mol) of DMF5 mA −
Add a mixture of THF 20- and further add tisc・HC
l 3.45g (18,0011101) of DMF
5 A mixture of at-THF 20- was added and stirred at 0°C for 1 hour and in a cold room (+4°C) overnight. After the reaction, it was concentrated under reduced pressure, and a 5% aqueous citric acid solution was added to the residue, and the resulting precipitate was was collected by filtration, washed with 5% sodium bicarbonate solution and water in that order, and the desired Boc-
Ala-Ser(Bzl)-11e-Leu-Gly-
10.8 g (93.5 mmol) of OPac was obtained.

融点:  169−171°C TLC: 0.76 (C: M :^、90:10:
1)(α) ”−−13,0° (c −1,0,DM
F)元素分析値 C4゜H57NSO1゜・H!0とし
てCHN 理論値(%)  61.13 7.57 8.91実測
値(%)  60,88 7.32 8.99参考例1
2 Boc−Ala−Ser  Bzl)−11e−Leu
−Gl  −OHのBoC−Ala−Ser(Bzl)
−11e−Leu−Gly−OPac 4.77g(6
,01s+5ol)を90%酢酸水溶液80−に溶かし
、活性化した亜鉛末を11.8g (18111+++
ol)を加え、室温で4時間激しく撹拌した。亜鉛末を
濾取した後、酢酸を減圧留去し、残渣に、10%クエン
酸水溶液を加え沈澱化し、水で洗浄した。減圧乾燥後、
DMF−エーテルで、再沈澱し、目的のBoc−Ala
−Ser(Bzl)−11e−Leu−Gly−OH3
,98g (96,7%)を得た。
Melting point: 169-171°C TLC: 0.76 (C: M:^, 90:10:
1) (α) ”−−13,0° (c −1,0,DM
F) Elemental analysis value C4゜H57NSO1゜H! CHN as 0 Theoretical value (%) 61.13 7.57 8.91 Actual value (%) 60,88 7.32 8.99 Reference example 1
2 Boc-Ala-Ser Bzl)-11e-Leu
-Gl-OH BoC-Ala-Ser(Bzl)
-11e-Leu-Gly-OPac 4.77g (6
,01s+5ol) in 90% acetic acid aqueous solution 80-, and 11.8g of activated zinc powder (18111+++
ol) was added and stirred vigorously at room temperature for 4 hours. After filtering the zinc dust, acetic acid was distilled off under reduced pressure, and a 10% aqueous citric acid solution was added to the residue to precipitate it, which was washed with water. After drying under reduced pressure,
Reprecipitate with DMF-ether to obtain the desired Boc-Ala.
-Ser(Bzl)-11e-Leu-Gly-OH3
, 98g (96.7%) was obtained.

融点;  20?−9°C(分解) TLCio、30 (COMMA、  9o:io: 
 1)〔α)  ”=−15,1”  (c瓢1.0.
  DMF)元素分析値 CatHsiNsOq ” 
3/4LOとしてCl      N 理論値(%)  57,94 7.98 10.56実
測値(%)  57,43 7.86 11.06アξ
ノ酸分析; Ser O,92(1)、 Gly 1.
06(1)Ala O,98(1)、  lie 1.
00(1)Leu  1.04(1) 参考例13 Boc−T r(Br−Z)−Leu−OPacの文献
記載(Ger、 0ffen、 DE3428942(
1985) )の方法により調整したBoa−Leu−
OPac 17.5g(50,0−mol)を塩化メチ
レン100−に溶かし、0℃冷却下、トリフルオロ酢酸
43−を加え、0℃冷冷却上1.5間、室温で2.5時
間攪拌した0反応後、混合液にエーテルを加え、生じた
沈澱を濾取した。得られた沈澱をDMF 100−に溶
かし、0℃冷却下、N−メチルモルホリンでpH7に調
整した。一方、Boc−Tyr(Br−Z)−0829
,7g(60,0g*5ol)、HOBt 9.22g
 (60,0++usol)をDMF 50−に溶かし
、0℃冷却下DCC14,9g(72,3+u+ol)
のTHF溶液5〇−を加え、0℃冷却下40分間攪拌し
た。この溶液を前記の溶液へ加え、0℃で4時間、低温
室(+4℃)で−晩撹拌した0反応後、析出した沈澱物
を濾取し、減圧濃縮後、残渣を酢酸エチル300−に溶
かし、10%クエン酸水溶液、5%重曹水、水の順で洗
浄し、無水硫酸ナトリウムで乾燥した。減圧II′a後
、残渣にエーテル−n−へキサン(1: 6) 350
 @lを加え、生じた沈澱を濾取し、目的のBoa−T
yr(Br−Z) −Leu−OPac36.3g (
100%)を得た。
Melting point; 20? -9°C (decomposition) TLCio, 30 (COMMA, 9o:io:
1) [α) ”=-15,1” (c 1.0.
DMF) elemental analysis value CatHsiNsOq”
ClN as 3/4LO Theoretical value (%) 57,94 7.98 10.56 Actual value (%) 57,43 7.86 11.06Aξ
Noic acid analysis; Ser O, 92(1), Gly 1.
06(1) Ala O, 98(1), lie 1.
00(1)Leu 1.04(1) Reference Example 13 Literature description of Boc-Tr(Br-Z)-Leu-OPac (Ger, Offen, DE3428942(
Boa-Leu- prepared by the method of (1985))
17.5 g (50.0-mol) of OPac was dissolved in 100-mol of methylene chloride, 43-trifluoroacetic acid was added under cooling at 0°C, and the mixture was stirred for 1.5 hours at 0°C and then at room temperature for 2.5 hours. After the reaction, ether was added to the mixture, and the resulting precipitate was collected by filtration. The obtained precipitate was dissolved in DMF 100- and adjusted to pH 7 with N-methylmorpholine while cooling at 0°C. On the other hand, Boc-Tyr(Br-Z)-0829
,7g (60,0g*5ol), HOBt 9.22g
(60,0++usol) was dissolved in DMF 50-, and DCC14.9g (72,3+u+ol) was cooled at 0℃.
50 - of THF solution was added, and the mixture was stirred for 40 minutes while cooling at 0°C. This solution was added to the above solution and stirred at 0°C for 4 hours and in a cold room (+4°C) overnight. After the reaction, the precipitate was collected by filtration, concentrated under reduced pressure, and the residue was diluted with 300% ethyl acetate. It was dissolved, washed in this order with a 10% aqueous citric acid solution, a 5% aqueous sodium bicarbonate solution, and water, and dried over anhydrous sodium sulfate. After pressure reduction II'a, ether-n-hexane (1:6) was added to the residue at 350
@l was added, the resulting precipitate was collected by filtration, and the desired Boa-T
yr(Br-Z)-Leu-OPac36.3g (
100%) was obtained.

融点:98−9℃ TLC:0.92 (C:M、 9: 1)〔α) ”
−一5.4 @(c −1−01MeOH)元素分析値
 C5JatNxOJr ・3/2HzOとしてC)I
    N 理論値(%)  57,45 5,89 3.72実測
値(%)  57.29 5,53 3.85参考例1
4 Boc−L 5(Cl−Z)−T r(Br−Z)−L
eu−OPacのBoc−Tyr(Br−Z)−Leu
−OPac 2.18g (3,00ssol)を0℃
冷却下、トリフルオロ酢酸4−を加え。
Melting point: 98-9℃ TLC: 0.92 (C:M, 9:1) [α)”
-5.4 @(c -1-01MeOH) elemental analysis value C5JatNxOJr ・C)I as 3/2HzO
N Theoretical value (%) 57,45 5,89 3.72 Actual value (%) 57.29 5,53 3.85 Reference example 1
4 Boc-L 5(Cl-Z)-Tr(Br-Z)-L
Boc-Tyr(Br-Z)-Leu of eu-OPac
-OPac 2.18g (3,00ssol) at 0℃
Add trifluoroacetic acid 4- while cooling.

0℃冷却下1時間攪拌した。反応後、混合液にn−へキ
サンを加え、生じた沈澱を濾取した。
The mixture was stirred for 1 hour while cooling at 0°C. After the reaction, n-hexane was added to the mixture, and the resulting precipitate was collected by filtration.

得られた沈澱をTI(F 35−に溶かし、0℃冷却下
、N−メチルモルホリンでpH7に調整した。一方、B
oa−Lys(Cl−Z)−0H1,49g (3,6
0ssol) 、HOBtO,55g (3,59ss
ol)をDMF 5aj−THF 25wJの混合液に
溶かし、O℃冷却下DCC0,89g (4,32gm
ol)を加え、0℃冷却下40分間攪拌した。この溶液
を前記の溶液へ加え、0℃で1時間、低温室(+4℃)
で−晩撹拌した。反応後、析出した沈澱物を濾取し、減
圧濃縮後、残渣を酢酸エチル300−に溶かし、10%
クエン酸水溶液、5%重曹水、水の順で洗浄し、無水硫
酸ナトリウムで乾燥した。減圧:a縮径、残渣にエーテ
ルを加え、生じた沈澱を濾取し、目的(7)Boc−L
ys(C1−Z)−Tyr(Br−Z)−Leu−OP
ac 2.14g(69,6%)を得た。
The obtained precipitate was dissolved in TI (F35-), and the pH was adjusted to 7 with N-methylmorpholine while cooling at 0°C.
oa-Lys(Cl-Z)-0H1,49g (3,6
0ssol), HOBtO, 55g (3,59ss
ol) was dissolved in a mixed solution of DMF 5aj-THF 25wJ, and 0.89g of DCC (4.32gm
ol) was added thereto, and the mixture was stirred for 40 minutes while cooling at 0°C. This solution was added to the above solution and kept at 0°C for 1 hour in a cold room (+4°C).
The mixture was stirred overnight. After the reaction, the precipitate was collected by filtration, concentrated under reduced pressure, and the residue was dissolved in 300% ethyl acetate.
It was washed in the following order: citric acid aqueous solution, 5% sodium bicarbonate solution, and water, and dried over anhydrous sodium sulfate. Reduced pressure: a diameter reduction, ether was added to the residue, the resulting precipitate was collected by filtration, and the objective (7) Boc-L
ys(C1-Z)-Tyr(Br-Z)-Leu-OP
2.14 g (69.6%) of ac was obtained.

融点;89−91℃ TLC: 0.58 (C:訓^、90:10:1)(
α)”−−16,2° (C−1,0,DMF)元素分
析値 C5JssNaOtJr−Cl−Elloとして
Cl      N 理論値(%)  57,72 5.81 5.39実測
値(%)  57.80 5,57 5.47参考例1
5 Boc−Leu−Gln−OHの  H−Gin−OH6,14g (42,0++usol
)を水70@Zに溶かし、0℃冷却下、トリエチルア逅
ン6aZ (42,0mmol)のTHF溶液18−1
Boc−Leu−OSu 11.5g(35,0mmo
l)のTHF溶液70−の順に加え、低温室(+4℃)
で−晩撹拌した0反応後、減圧濃縮し、残渣を酢酸エチ
ル200−に溶かし、10%クエン酸水溶液、5%重曹
水、水の順で洗浄し、無水硫酸ナトリウムで乾燥した。
Melting point: 89-91°C TLC: 0.58 (C:Kun^, 90:10:1) (
α)”--16,2° (C-1,0,DMF) Elemental analysis value C5JssNaOtJr-Cl-Ello as ClN Theoretical value (%) 57,72 5.81 5.39 Actual value (%) 57. 80 5,57 5.47 Reference example 1
5 Boc-Leu-Gln-OH H-Gin-OH6,14g (42,0++ usol
) in water 70@Z and cooled at 0°C to form a THF solution 18-1 of triethylamine 6aZ (42.0 mmol).
Boc-Leu-OSu 11.5g (35,0mmo
Add the THF solution of l) in order of 70°C and store in a cold room (+4°C).
After the reaction was stirred overnight, the reaction mixture was concentrated under reduced pressure, and the residue was dissolved in 200% ethyl acetate, washed successively with a 10% aqueous citric acid solution, a 5% aqueous sodium bicarbonate solution, and water, and dried over anhydrous sodium sulfate.

減圧濃縮後、残渣にエーテル−n−ヘキサン(1:1)
を加え、生じた沈澱を濾取し、目的のBoc−Leu−
GIn−OH8,58g (68,2%)を得た。
After concentration under reduced pressure, ether-n-hexane (1:1) was added to the residue.
was added, the resulting precipitate was collected by filtration, and the desired Boc-Leu-
8.58 g (68.2%) of GIn-OH was obtained.

融点、87−90°C TLCi 0.77 (B :^;肌 90:10: 
l)〔α) tS= −21,2° (c −1,0+
  MeOFI)元素分析値 ClJtJxOhとして CHN 理論値(%)  53.47 8.13 11゜69実
測値(%)  53.55 8.46 11.11参考
例16 Boa−Leu−Gin−L s C1−Z −T r
 Br−Z)−Leu−OPacの製造 Boc−Lys(Cl−Z)−Tyr(Br−Z)−L
eu−OPac 7.15g(7,OOmmol)をo
 ”c冷却下、トリフルオロ酢酸i。
Melting point, 87-90°C TLCi 0.77 (B:^; skin 90:10:
l) [α) tS= -21,2° (c -1,0+
MeOFI) Elemental analysis value CHN as ClJtJxOh Theoretical value (%) 53.47 8.13 11°69 Actual value (%) 53.55 8.46 11.11 Reference example 16 Boa-Leu-Gin-L s C1-Z -Tr
Production of Boc-Lys(Cl-Z)-Tyr(Br-Z)-L
7.15 g (7,00 mmol) of eu-OPac
"c under cooling, trifluoroacetic acid i.

−を加え、O″C冷却冷却下関時間撹拌0反応後、混合
液にエーテルを加え、生じた沈澱を濾取した。得られた
沈澱をTHF Loaf−DMF 30tIL1に溶か
し、0°C冷却下、N−メチルモルホリンでpH7に調
整した。この溶液に、Boa−Leu−Gin−OB 
3.79g(10,5mmo+) 、HOBt 1.6
1g (10,5mmol)のDMF5ml−THF 
7−溶液を加え、更に、WSC・IC112,25g 
(11,7m+mol)のDMF 10m1−TIIF
 10−の混合液を加え、低温室(+4°C)で−晩撹
拌した。
After the reaction, ether was added to the mixture and the resulting precipitate was collected by filtration.The resulting precipitate was dissolved in THF Loaf-DMF 30tIL1, and cooled at 0°C. The pH was adjusted to 7 with N-methylmorpholine.To this solution, Boa-Leu-Gin-OB
3.79g (10.5mmo+), HOBt 1.6
1g (10,5mmol) of DMF 5ml-THF
7-Add the solution and add WSC・IC112, 25g
(11,7m+mol) of DMF 10m1-TIIF
A mixture of 10 and 10% was added, and the mixture was stirred overnight in a cold room (+4°C).

反応後、減圧濃縮し、残渣に5%クエン酸水溶液を加え
、生じた沈澱を濾取し、5%重曹水、水の順で洗浄した
。減圧乾燥後、DMF−AcOEtで再沈澱を行い、目
的のBoc−Leu−Gln−Lys(Cl−Z)−T
yr (Br−Z)−Leu−OPac 8.54g 
(96,5%)を得た。
After the reaction, the mixture was concentrated under reduced pressure, a 5% aqueous citric acid solution was added to the residue, and the resulting precipitate was collected by filtration and washed with a 5% aqueous sodium bicarbonate solution and then water. After drying under reduced pressure, reprecipitation is performed with DMF-AcOEt to obtain the desired Boc-Leu-Gln-Lys(Cl-Z)-T.
yr (Br-Z)-Leu-OPac 8.54g
(96.5%) was obtained.

融点、195−96℃ TLC;o、ao (C:M:A 、 9o: 1o:
 1 ”)〔α) ”−−19,4° (c =1.0
. DMF)元素分析値 Ch+HtqNrO01C1
−Br−1120としてCl(N 理論値(%)  53,47 8.13 11.69実
測値(%)  53,55 8.46 11.11参考
例17 Boc−Leu、Gin−L s C1−Z −T r
(Br−Z −Leu−ORの盈 Boc−Leu−Gin−Lys (Cl−Z)−Ty
r(Br−Z) −Leu−OPac6.32g (5
,00+gnol)を90%酢酸水溶液60m7に溶か
し、活性化した亜鉛末19.6g (300mmol)
を加え、室温で一晩激しく撹拌した。亜鉛末を濾取した
後、酢酸を減圧留去し、残渣に、10%クエン酸水溶液
を加え沈澱化し、水で洗浄した。減圧乾燥後、D?lF
−エーテルで、再沈澱し、目的のB。
Melting point, 195-96°C TLC; o, ao (C:M:A, 9o: 1o:
1 ”) [α) ”--19,4° (c = 1.0
.. DMF) Elemental analysis value Ch+HtqNrO01C1
-Br-1120 as Cl(N Theoretical value (%) 53,47 8.13 11.69 Actual value (%) 53,55 8.46 11.11 Reference example 17 Boc-Leu, Gin-L s C1-Z -Tr
(Br-Z-Leu-OR of Boc-Leu-Gin-Lys (Cl-Z)-Ty
r(Br-Z)-Leu-OPac6.32g (5
,00+gnol) in 60ml of 90% acetic acid aqueous solution and activated zinc powder 19.6g (300mmol)
was added and stirred vigorously at room temperature overnight. After filtering the zinc dust, acetic acid was distilled off under reduced pressure, and a 10% aqueous citric acid solution was added to the residue to precipitate it, which was washed with water. After drying under reduced pressure, D? lF
-Re-precipitate with ether to obtain the desired B.

c−Leu−Gin−Lys(Cl−Z)−Tyr(B
r−Z)−Leu−0!I  4.36g (76,1
%)を得た。
c-Leu-Gin-Lys(Cl-Z)-Tyr(B
r-Z)-Leu-0! I 4.36g (76,1
%) was obtained.

融点;190−92°C TLCiO,10(C1:A 、 9o:to: 1)
(α) ”=−17,6”  (C=1.0. DMF
)元素分析値 C5Jt+N、0+4・Cl−Br ・
2/3H!Oとして CHN 理論値(%)54,99 6.30 8.47実測値(
%)  54,69 6.26 8.64アミノ酸分析
; Gin 1.02(1)、 Leu 2.08(2
)Tyr O,93(1)、  Lys O,96(1
)参考例18 Boc−Leu−Ala−OPacの ″文献記載(G
er、 0ffen、 DE3428942 )の方法
により調整したBoc−Ala−OPac 20.Og
 (65,1sa+ol)を、0°C冷却冷却ジトリフ
ルオロ酢酸30溶かし、4時間撹拌した0反応後、減圧
濃縮し、残渣にエーテルを加え、生じた沈澱を濾取した
。得られた沈澱をDMF 25d −TI(F 550
17に溶かし、0℃冷却下、N−メチルモルホリンでp
H7に調整した。一方、Boc−Leu−OH−Hto
 17.9g (71,6mmol)を酢酸エチル15
0−に溶解し硫酸ナトリウムで乾燥する。減圧濃縮し、
残渣とHOBt 11.Og(71,6v++ol)を
DMF 20aj −THF 40−の混合液に溶かし
、O℃冷却下DCCl6.3g (78,8開o1)の
T)IF溶液3〇−を加え、O℃冷却下30分間攪拌し
た。この溶液を前記の溶液へ加え、0℃で2時間、低温
室(+4℃〉で−晩撹拌した。反応後、析出した沈澱物
を濾取し、減圧iJI縮後縮径渣を酢酸エチル300−
に溶かし、10%クエン酸水溶液、5%重曹水、水の順
で洗浄し、無水硫酸ナトリウムで乾燥した。減圧濃縮後
、残渣にエーテル−n−へキサン(1: 1)を加え、
生じた沈澱を濾取し、目的のBoc−Leu−Ala−
OPac 21.9g (80,3%)を得た。
Melting point: 190-92°C TLCiO, 10 (C1:A, 9o:to: 1)
(α) ”=-17,6” (C=1.0. DMF
) Elemental analysis value C5Jt+N, 0+4・Cl-Br・
2/3H! CHN as O Theoretical value (%) 54,99 6.30 8.47 Actual value (
%) 54,69 6.26 8.64 Amino acid analysis; Gin 1.02 (1), Leu 2.08 (2
) Tyr O, 93 (1), Lys O, 96 (1
) Reference Example 18 ``Literature description of Boc-Leu-Ala-OPac'' (G
Boc-Ala-OPac 20. Og
(65,1sa+ol) was dissolved in ditrifluoroacetic acid at 0° C. and stirred for 4 hours. After the reaction, it was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration. The obtained precipitate was dissolved in DMF 25d-TI (F 550
17 and diluted with N-methylmorpholine under cooling at 0°C.
Adjusted to H7. On the other hand, Boc-Leu-OH-Hto
17.9g (71.6mmol) of ethyl acetate15
0- and dry with sodium sulfate. Concentrate under reduced pressure,
Residue and HOBt 11. Dissolve Og (71,6v++ol) in a mixture of DMF 20aj -THF 40-, add 30- of T)IF solution of 6.3 g DCCl (78,8 open o1) under cooling at 0°C, and cool for 30 minutes at 0°C. Stirred. This solution was added to the above solution and stirred for 2 hours at 0°C and overnight in a cold room (+4°C). After the reaction, the precipitate precipitated was collected by filtration, and the reduced diameter residue after reduction with iJI was reduced to 300% in ethyl acetate. −
The solution was washed with a 10% aqueous citric acid solution, a 5% aqueous sodium bicarbonate solution, and water in this order, and dried over anhydrous sodium sulfate. After concentration under reduced pressure, ether-n-hexane (1:1) was added to the residue,
The resulting precipitate was collected by filtration, and the desired Boc-Leu-Ala-
21.9 g (80.3%) of OPac were obtained.

融点;131−32℃ TLC;0.60 (C:M+ 9: 1)〔α)  
”=−73,5”  (c −1,0,MeOH)元素
分析値 C2□H:12N206・1/2+1□Oとし
てCHN 理論値(%)  61.52 7.74 6.52実測
値(%)  61.75 7.56 6.55実施例1
9 Boc−L 5(Cl−Z)−Leu−Ala−OPa
cの製Boc−Leu−Ala−OPac 10.1g
 (24,Ommol)をO℃冷却下40%トリフルオ
ロ酢酸−塩化メチレン溶液に溶かし、5時間攪拌した。
Melting point: 131-32°C TLC: 0.60 (C:M+ 9: 1) [α)
"=-73,5" (c -1,0,MeOH) Elemental analysis value CHN as C2□H:12N206・1/2+1□O Theoretical value (%) 61.52 7.74 6.52 Actual value (% ) 61.75 7.56 6.55 Example 1
9 Boc-L 5(Cl-Z)-Leu-Ala-OPa
Boc-Leu-Ala-OPac manufactured by c. 10.1g
(24, Ommol) was dissolved in a 40% trifluoroacetic acid-methylene chloride solution under cooling at 0°C and stirred for 5 hours.

反応後、減圧濃縮し、残渣にエーテル−〇−へキサンを
加え、生じた沈澱を濾取した。得られた沈澱をTHF 
60−に溶かし、0℃冷却下、N−メチルモルホリンで
p)17に調整した。一方、Boc−Lys(Cl−Z
) −0R11,0g (26,5mmol)とHOB
t 4.01g (26,5開o1)をDMF 20t
n!−THP 30mZの混合液に溶かし、0℃冷却下
DCC5,95g (28,8mmol)のTFIF溶
液20−を加え、0℃冷却下50分間攪拌した。この溶
液を前記の溶液へ加え、0℃で2時間、低温室(+4℃
〉で−晩撹拌した。反応後、析出した沈澱物を濾取し、
減圧濃縮後、残渣に10%クエン酸水溶液を加え、生じ
た沈澱を濾取し、5%重曹水、水の順で洗浄し、目的の
Boc−Lys(Cl−Z)−Leu−^1a−OPa
c 17.2g (100%)を得た。
After the reaction, the mixture was concentrated under reduced pressure, ether-0-hexane was added to the residue, and the resulting precipitate was collected by filtration. The obtained precipitate was dissolved in THF.
60- and adjusted to p)17 with N-methylmorpholine while cooling at 0°C. On the other hand, Boc-Lys(Cl-Z
) -0R11,0g (26,5mmol) and HOB
t 4.01g (26.5 open o1) in DMF 20t
n! -THP 30mZ was dissolved in a mixed solution of 30mZ, and a TFIF solution of 5.95 g (28.8 mmol) of DCC was added to the mixture under cooling at 0°C, followed by stirring for 50 minutes under cooling at 0°C. This solution was added to the previous solution and kept at 0°C for 2 hours in a cold room (+4°C).
> overnight. After the reaction, the precipitate was collected by filtration,
After concentration under reduced pressure, a 10% aqueous citric acid solution was added to the residue, and the resulting precipitate was collected by filtration and washed with 5% aqueous sodium bicarbonate and water in that order to obtain the desired Boc-Lys(Cl-Z)-Leu-^1a- OPa
17.2 g (100%) of c was obtained.

融点;145−46°C TLC;0.53 (C:?I:A 、 9o:to:
 1)〔α) ”=−57,4° (c −1,0+ 
MeOH)元素分析値 C36H49N409Clとし
てCHN 理論値(%)  60.28 6.89 7.81実測
値(%)  60.28 6.99 7.87実施例2
0 Boc−Ala−L s C1−Z −Leu−Ala
−OPacのBoc−Lys(C1−Z)−Leu−A
la−OPac 10.Og (14,0m+5ol)
をO℃冷却下トリフルオロ酢酸15m7に溶かし、1時
間撹拌した0反応後、減圧濃縮し、残渣にエーテルを加
え、生じた沈澱を濾取した。
Melting point; 145-46°C TLC; 0.53 (C:?I:A, 9o:to:
1) [α) ”=-57,4° (c -1,0+
MeOH) Elemental analysis value CHN as C36H49N409Cl Theoretical value (%) 60.28 6.89 7.81 Actual value (%) 60.28 6.99 7.87 Example 2
0 Boc-Ala-L s C1-Z -Leu-Ala
-OPac Boc-Lys(C1-Z)-Leu-A
la-OPac 10. Og (14,0m+5ol)
was dissolved in 15 m7 of trifluoroacetic acid under cooling at 0°C, stirred for 1 hour, and then concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected by filtration.

得られた沈澱をTI 30d−DMF 70−に溶かし
、0℃冷却下、N−メチルモルホリンでpl(7に調整
した。一方、Boc−Ala−OH2,78g (14
,7mmol)とll0Bt 2.25g (14,7
mmol)  をDMF  5d−TIIF 20−の
混合液に溶かし、0°C冷却下DCC3,47g(16
,8mmol)を加え、0°C冷却冷却下関撹拌した。
The obtained precipitate was dissolved in TI 30d-DMF 70-, and while cooling at 0°C, the pl was adjusted to 7 with N-methylmorpholine.
,7mmol) and ll0Bt 2.25g (14,7
mmol) was dissolved in a mixed solution of DMF 5d-TIIF 20-, and 3.47 g (16 mmol) of DCC was added under cooling to 0°C.
, 8 mmol) was added, and the mixture was cooled to 0°C and stirred in Shimonoseki.

この溶液を前記の溶液へ加え、O′Cで1時間、低温室
(+4°C)で−晩撹拌した。反応後、析出した沈澱物
を濾取し、減圧濃縮後、残渣に10%クエン酸水溶液を
加え、生じた沈澱を濾取し、5%重曹水、水の順で洗浄
した。減圧乾燥後、メタノール−エーテルで沈澱を行い
、目的のBocAla−Lys(C1−Z)−Leu−
Ala−OPac 9.15g (82,6%)を得た
This solution was added to the previous solution and stirred for 1 hour at O'C and overnight in a cold room (+4°C). After the reaction, the deposited precipitate was collected by filtration, and after concentration under reduced pressure, a 10% aqueous citric acid solution was added to the residue, the resulting precipitate was collected by filtration, and washed with 5% aqueous sodium bicarbonate and water in this order. After drying under reduced pressure, precipitation is performed with methanol-ether to obtain the desired BocAla-Lys(C1-Z)-Leu-
9.15 g (82.6%) of Ala-OPac was obtained.

融点;140−41”C TLC;0.55 (COMMA 、 90:10:1
)(α) ”=−31,3° (c =1.0. DM
F)元素分析値 C3gHsJsO+。・ClとしてC
ON 理論値(%)  59.12 6,96 9.00実測
値(%)  59.42 6.90 8.88参考例2
1 Boc−Leu−Ala−L  5(Cl−Z)−Le
u−Ala−OPacのBoc−^1a−Lys(Cl
−Z)−Leu−Ala−OPac 6.30g(8,
00vwol)をO″C冷却下トリフルオロ酢酸10a
Zに溶かし、1時間撹拌した。反応後、減圧1Ji1L
、残渣にエーテルを加え、生じた沈澱を濾取した。
Melting point: 140-41"C TLC: 0.55 (COMMA, 90:10:1
)(α)”=-31,3° (c=1.0. DM
F) Elemental analysis value C3gHsJsO+.・C as Cl
ON Theoretical value (%) 59.12 6,96 9.00 Actual value (%) 59.42 6.90 8.88 Reference example 2
1 Boc-Leu-Ala-L 5(Cl-Z)-Le
Boc-^1a-Lys(Cl
-Z)-Leu-Ala-OPac 6.30g (8,
00vwol) to 10a of trifluoroacetic acid under cooling at O''C.
It was dissolved in Z and stirred for 1 hour. After reaction, reduce pressure 1Ji1L
Ether was added to the residue, and the resulting precipitate was collected by filtration.

得られた沈澱をTHF 10m−DMF 100−に溶
かし、O″C冷却下、N−メチルモルホリンでpH7に
調整した。一方、Boc−Leu−OR−Hzo 4.
OOg (16,Ommol)の酢酸エチル100−に
溶解し硫酸ナトリウムで乾燥する。減圧濃縮し、残渣と
HOBt 2.46g(16,Ommol)をDMF 
20WL!−T)IF 10m7の混合液に溶かし、0
°C冷却下DCC3,64g (17,6mmol)の
TIIF溶液10−を加え、O″C冷却下1時間撹拌し
た。
The obtained precipitate was dissolved in THF 10m-DMF 100- and adjusted to pH 7 with N-methylmorpholine while cooling at O''C.Meanwhile, Boc-Leu-OR-Hzo4.
Dissolve OOg (16, Ommol) in ethyl acetate 100- and dry with sodium sulfate. Concentrate under reduced pressure, and dissolve the residue and 2.46 g (16, Ommol) of HOBt in DMF.
20WL! -T) IF Dissolved in 10m7 of mixed solution, 0
A solution of 3.64 g (17.6 mmol) of DCC in TIIF 10- was added under cooling at °C, and the mixture was stirred for 1 hour under cooling at O''C.

この溶液を前記の溶液へ加え、0°Cで1時間、低温室
(+4°C)で−晩撹拌した。反応後、析出した沈澱物
を濾取し、減圧濃縮後、5%重曹水を加え、生じた沈澱
を濾取し、10%クエン酸水溶液、水の順で洗浄した。
This solution was added to the previous solution and stirred for 1 hour at 0°C and overnight in a cold room (+4°C). After the reaction, the precipitate deposited was collected by filtration, concentrated under reduced pressure, 5% aqueous sodium bicarbonate was added, the resulting precipitate was collected by filtration, and washed with a 10% aqueous citric acid solution and water in that order.

減圧乾燥後、DMF酢酸エチルで沈澱を行い、目的のB
oc−Leu−^IaLys (Cl −Z) −Le
u−^1a−OPac 7.21g (100%)を得
た。
After drying under reduced pressure, precipitate with DMF ethyl acetate to obtain the desired B
oc-Leu-^IaLys (Cl -Z) -Le
7.21 g (100%) of u-^1a-OPac was obtained.

融点: 180−81”C TLCio、78 (C:M:A 、  90:10:
  1)(α) ”=−27,9@(c=1.0.  
DMF)元素分析値 C45HisNaO□・ci・3
/2HgoとしてCFI      N 理論値(%)  58.23 7,34 9.05実測
値(%)  58,13 7.15 9.29参考例2
2 Boc−Leu−Leu−Ala−L  5(Cl−Z
)−Leu−^1a−OPacの遣 Boc−Leu−^1a−Lys(Cl−Z)−Leu
−Ala−OPac 5.42g(6,OOmmol)
をO′C冷却下トリフルオロ酢酸15m7に溶かし、3
0分間撹拌した。反応後、減圧?a縮し、残渣にエーテ
ルを加え、生じた沈澱を濾取した。得られた沈澱をDM
F 60−に溶かし、0°C冷却下、N−メチルモルホ
リンでpH7に調整した。一方、Boc−Leu−OH
−Hzo 1.79g (7,18+nol)の酢酸エ
チル100−に溶解し硫酸ナトリウムで乾燥する。減圧
濃縮し、残渣とHOBt 1.11g(7,23w5o
l)をDMF 15aZ−THF 60g1jの混合液
に溶かし、0℃冷却下−5C−HCl 1.52g (
7,95a+mol)を加え、O″C冷却冷却下関時間
撹拌。この溶液を前記の溶液へ加え、O″Cで2時間、
低温室(+4°C)で−晩撹拌した。反応後、減圧濃縮
後、5%重曹水を加え、生じた沈澱を濾取し、10%ク
エン酸水溶液、水の順で洗浄した。減圧乾燥後、DMF
−メタノールで再沈澱を行い、目的のBoc−Leu−
Leu−Ala−Lys(Cl−Z)−Leu−Ala
−OPac 7.28g (83,6%)を得た。
Melting point: 180-81"C TLCio, 78 (C:M:A, 90:10:
1)(α)”=-27,9@(c=1.0.
DMF) Elemental analysis value C45HisNaO□・ci・3
CFIN as /2Hgo Theoretical value (%) 58.23 7,34 9.05 Actual value (%) 58,13 7.15 9.29 Reference example 2
2 Boc-Leu-Leu-Ala-L 5(Cl-Z
)-Leu-^1a-OPac's transfer Boc-Leu-^1a-Lys(Cl-Z)-Leu
-Ala-OPac 5.42g (6,00mmol)
was dissolved in 15 m7 of trifluoroacetic acid under O'C cooling, and 3
Stirred for 0 minutes. Depressurize after reaction? After condensation, ether was added to the residue, and the resulting precipitate was collected by filtration. DM the obtained precipitate
The mixture was dissolved in F60- and adjusted to pH 7 with N-methylmorpholine while cooling at 0°C. On the other hand, Boc-Leu-OH
Dissolve 1.79 g (7,18+nol) of -Hzo in ethyl acetate 100- and dry with sodium sulfate. It was concentrated under reduced pressure, and the residue and HOBt 1.11g (7,23w5o
1) was dissolved in a mixed solution of DMF 15aZ-THF 60g 1j, and -5C-HCl 1.52g (
7,95a + mol) and stirred at O″C for 2 hours. Add this solution to the above solution and stir at O″C for 2 hours.
Stir overnight in a cold room (+4°C). After the reaction and concentration under reduced pressure, 5% aqueous sodium bicarbonate was added, and the resulting precipitate was collected by filtration and washed with a 10% aqueous citric acid solution and water in that order. After drying under reduced pressure, DMF
- Perform reprecipitation with methanol to obtain the desired Boc-Leu-
Leu-Ala-Lys(Cl-Z)-Leu-Ala
-OPac 7.28g (83.6%) was obtained.

融点; 188−89°C TLC; 0.95 (C: M :^、90:10:
1)(α) ”= −33,7° (c=1.0. D
MF)元素分析値 (: s ll −t h N ?
 0 +□・C1・1/2H,0としてCl     
 N 理論値(%)  59.84 7.58 9.58実測
値(%)  59,83 7.55 9.54参考例2
3 Boa−Lea−Leu−Ala−Lys (Cl−Z
)−Leu−Ala−OPac3.03g(2,99a
+5ol)をO″C冷却下トリフルオロ酢酸15−に溶
かし、1時間撹拌した0反応後、減圧濃縮し、残渣にエ
ーテルを加え、生じた沈澱を濾取した。得られた沈澱を
[)MP 30afに溶かし、0゛C冷却下、N−メチ
ルモルホリンでpH7に調整した。この溶液に、0°C
冷却下、Boc−Lys (Cl−Z)−081,49
g (3,60開01)とll0Bt O,56g(3
,66mmol)のDMF 5−の混合液を加え、更に
−SC−HCl 0.83g (4,33m5+ol)
を加え、O″C1低温室(+4°C)で−晩撹拌した。
Melting point; 188-89°C TLC; 0.95 (C: M:^, 90:10:
1) (α) ”= −33,7° (c=1.0.D
MF) Elemental analysis value (: s ll -t h N ?
0 +□・C1・1/2H, Cl as 0
N Theoretical value (%) 59.84 7.58 9.58 Actual value (%) 59,83 7.55 9.54 Reference example 2
3 Boa-Lea-Leu-Ala-Lys (Cl-Z
)-Leu-Ala-OPac3.03g (2,99a
+5ol) was dissolved in trifluoroacetic acid 15- while cooling at O''C and stirred for 1 hour. After the reaction, it was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration.The resulting precipitate was [)MP 30af and adjusted to pH 7 with N-methylmorpholine while cooling at 0°C.
Under cooling, Boc-Lys (Cl-Z)-081,49
g (3,60 open 01) and ll0Bt O,56g (3
, 66 mmol) of DMF 5- was added, and further -SC-HCl 0.83 g (4,33 m5+ol)
was added and stirred overnight in an O''C1 cold room (+4°C).

反応後、減圧濃縮後、10%クエン酸水溶液を加え、生
じた沈澱を濾取し、5%重曹水、水の順で洗浄した。減
圧乾燥後、DMF−メタノールで再沈澱を行い、目的の
Boc−LyS(Cl−Z) −Leu−Leu−Al
a−Lys (Cl−Z) −Leu−^1a−OPa
c3.21g (82,0%)を得た。
After the reaction and concentration under reduced pressure, a 10% aqueous citric acid solution was added, and the resulting precipitate was collected by filtration and washed successively with a 5% aqueous sodium bicarbonate solution and water. After drying under reduced pressure, reprecipitation is performed with DMF-methanol to obtain the desired Boc-LyS(Cl-Z)-Leu-Leu-Al.
a-Lys (Cl-Z) -Leu-^1a-OPa
c3.21g (82.0%) was obtained.

融点;212−14°C TLC; 0.58 (C: M :^、90:10:
i)(α) ”=−31,4@(c=1.0. DMF
)元素分析値 CthsHqJqO+1CL・3/21
1□Oとし1 理論値(%) 実測値(%) 参考例24 58.33 7.23 9.42 58.09 7.04  9.45 Boc−Lys (Cl−Z) −Leu−Leu−A
la−Lys (Cl−Z) −Leu−Ala−OP
ac 3.39g(3,OOmmol)を95%酢酸水
溶液5〇−に溶かし、活性化した亜鉛末を5.88g 
(89,9mmol)を加え、室温で4.5時間激しく
撹拌した。
Melting point; 212-14°C TLC; 0.58 (C: M:^, 90:10:
i) (α) ”=-31,4@(c=1.0.DMF
) Elemental analysis value CthsHqJqO+1CL・3/21
1□O 1 Theoretical value (%) Actual value (%) Reference example 24 58.33 7.23 9.42 58.09 7.04 9.45 Boc-Lys (Cl-Z) -Leu-Leu-A
la-Lys (Cl-Z) -Leu-Ala-OP
Dissolve 3.39 g (3,00 mmol) of ac in 95% acetic acid aqueous solution, and add 5.88 g of activated zinc powder.
(89.9 mmol) was added and stirred vigorously at room temperature for 4.5 hours.

亜鉛末を濾取した後、酢酸を減圧留去し、残渣に10%
クエン酸水溶液を加え沈澱化し、水で洗浄した。減圧乾
燥後、DMF−エーテルで、再沈澱し、目的のBoc−
Lys (Cl−Z)−Leu−Leu−Ala−Ly
s(Cl−Z)−Leu−Aia−OR3,08g(8
6,0%)を得た。
After filtering the zinc dust, acetic acid was distilled off under reduced pressure, and 10%
A citric acid aqueous solution was added to precipitate the mixture, which was washed with water. After drying under reduced pressure, reprecipitation was performed with DMF-ether to obtain the desired Boc-
Lys (Cl-Z)-Leu-Leu-Ala-Ly
s(Cl-Z)-Leu-Aia-OR3,08g (8
6.0%) was obtained.

融点;205℃(分解) TLC,0,25(COMMA 、 90:10: 1
)〔α) ”=−29,1@(c =1.0. DMF
)元素分析値 CsJ@vN、0+ a・t、h・4/
3ozoとしCl(N 理論値(%)  56,24 7.42 10.36実
測値(%)  56.00 7.22 10.39アミ
ノ酸分析;^la 1,92(2)、 Leu 3.2
5(3)Lys 1.94(2) 参考例25 Boc−T r Br−Z −5er(Bzl−OPa
cのTosOH−1f−Set(Bzl)−0Pac 
7.93g (16,3mmol)をDMF 20sd
−THF 40−に溶かし、−15°C冷却下、N−メ
チルモルホリンでpH7に調整した。一方、Boc−T
yr(Br−Z)−088,85g(17,9mmol
)、HOBL 2.74g (17,9旧o1)をD?
IP 10mj−Tl 50−の混合液に溶かし、0°
C冷却下DCC4,01g(19,4ms+ol)のT
HF溶液5−を加え、O″C冷却下1.5時間撹拌した
Melting point: 205°C (decomposition) TLC, 0.25 (COMMA, 90:10:1
) [α) ”=-29,1@(c =1.0. DMF
) Elemental analysis value CsJ@vN, 0+ a・t, h・4/
3 ozo and Cl (N Theoretical value (%) 56.24 7.42 10.36 Actual value (%) 56.00 7.22 10.39 Amino acid analysis; ^la 1,92 (2), Leu 3.2
5(3)Lys 1.94(2) Reference Example 25 Boc-Tr Br-Z -5er(Bzl-OPa
c TosOH-1f-Set (Bzl)-0Pac
7.93g (16.3mmol) in DMF 20sd
It was dissolved in -THF 40- and adjusted to pH 7 with N-methylmorpholine while cooling at -15°C. On the other hand, Boc-T
yr(Br-Z)-088,85g (17,9mmol
), HOBL 2.74g (17.9 old o1) D?
Dissolve in a mixture of IP 10mj-Tl 50- and 0°
T of DCC4,01g (19,4ms+ol) under C cooling
HF solution 5- was added and stirred for 1.5 hours under cooling at O''C.

この溶液を前記の溶液へ加え、−20℃で1時間、0°
Cで2時間、低温室(+4℃)で−晩撹拌した。反応後
、析出した沈澱物を濾取し、減圧濃縮後、残渣を酢酸エ
チル300−に溶かし、10%クエン酸水溶液、5%重
曹水、飽和食塩水の順で洗浄し、無水硫酸ナトリウムで
乾燥した。減圧濃縮後、残渣にエーテル−石油エーテル
(1:l)を加え、生じた沈澱を濾取し、目的のBoc
−Tyr(Br−Z)−Ser(Bzl)−0Pac 
12.9g (100%)を得た。
Add this solution to the above solution and hold at -20°C for 1 hour at 0°C.
Stirred for 2 hours at C and overnight in a cold room (+4° C.). After the reaction, the precipitate precipitated was collected by filtration, concentrated under reduced pressure, and the residue was dissolved in 300% ethyl acetate, washed in this order with 10% citric acid aqueous solution, 5% sodium bicarbonate solution, and saturated brine, and dried over anhydrous sodium sulfate. did. After concentration under reduced pressure, ether-petroleum ether (1:l) was added to the residue, the resulting precipitate was collected by filtration, and the desired Boc
-Tyr(Br-Z)-Ser(Bzl)-0Pac
12.9g (100%) was obtained.

融点;95−8℃ TLCio、79 (CAM、 9: 1 ”)Cut
〕”−4,9″(c =−1,0+ MeOH)元素分
析値 C4゜Fln+NzO+。・BrとしてC)I 
     N 理論値(%)  60.84 5.23 3.55実測
値(%)  61.30 5.28 3.43参考例2
6 Boc−Gln−T r Br−Z−Ser(Bzl)
−0PacのBoc−Tyr(Br−Z)−Set(B
zl)−0Pac 6.33g (8,02mmol)
をO″C冷却下4N塩酸−ジオキサン溶液4〇−に溶か
し、1時間撹拌した。反応後、減圧濃縮し、残渣にエー
テルを加え、生じた沈澱を濾取した。得られた沈澱をT
HF IM−DMF 20−に溶かし、0°C冷却下、
N−メチルモルホリンでpH7に調整した。一方、Bo
c−Gin−OH2,37g(9,62IIllIlo
l) 、HOBt 1.63g (10,6mmol)
をDMF5d−THF 20−の混合液に溶かし、0℃
冷却下DCC2,37g (11,5mmol)のTI
P溶液5+7を加え、0℃冷却下40分間攪拌した。こ
の溶液を前記の溶液へ加え、0℃で1時間、低温室(+
4℃)で−晩撹拌した。反応後、析出した沈澱物を濾取
し、減圧濃縮後10%クエン酸水溶液を加え、生じた沈
澱を濾取し、5%重曹水、水の順で洗浄した。
Melting point: 95-8°C TLCio, 79 (CAM, 9:1”) Cut
]"-4,9" (c =-1,0+ MeOH) Elemental analysis value C4°Fln+NzO+.・Br as C)I
N Theoretical value (%) 60.84 5.23 3.55 Actual value (%) 61.30 5.28 3.43 Reference example 2
6 Boc-Gln-Tr Br-Z-Ser (Bzl)
-0Pac's Boc-Tyr(Br-Z)-Set(B
zl)-0Pac 6.33g (8.02mmol)
was dissolved in 4N hydrochloric acid-dioxane solution under cooling at O''C and stirred for 1 hour. After the reaction, it was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration.
Dissolved in HF IM-DMF 20- and cooled at 0°C.
The pH was adjusted to 7 with N-methylmorpholine. On the other hand, Bo
c-Gin-OH2, 37g (9,62IIllIlo
l), HOBt 1.63g (10.6mmol)
Dissolved in a mixture of DMF5d-THF20- and heated to 0°C.
2.37 g (11.5 mmol) of TI under cooling DCC
P solution 5+7 was added and stirred for 40 minutes while cooling at 0°C. This solution was added to the above solution and kept at 0°C for 1 hour in a cold room (+
The mixture was stirred overnight at 4°C. After the reaction, the precipitate deposited was collected by filtration, concentrated under reduced pressure, a 10% aqueous citric acid solution was added, and the resulting precipitate was collected by filtration and washed with 5% aqueous sodium bicarbonate and water in this order.

減圧乾燥後、メタノール−エーテルで沈′澱を行い、目
的のBoc−Gin−Tyr(Br−Z)−5et(B
zl) −0Pac6.85g (93,1%)を得た
After drying under reduced pressure, precipitation was performed with methanol-ether to obtain the desired Boc-Gin-Tyr(Br-Z)-5et(B
zl) -0Pac 6.85g (93.1%) was obtained.

融点1164−5℃ TLC;0.39 (C:M:A 、 90:10: 
1)〔α〕z5=−3,5@(C−1,0,DhF)元
素分析値 C!lH3゜N206としてCHN 理論イ直 (%)    62.05  7.44  
 6.89実測値(%)  62.06 7.51 6
.76参考例27 Boc−Gln−Gln−T r(Br−Z)−Set
(Bzl)−0Pacの1Boc−Gin−Tyr(B
r−Z)−Set(Bzl)−0Pac 5.51g(
6,00eamol)を0℃冷却下4N塩酸−ジオキサ
ン溶液45mfに溶かし、3.5時間撹拌した。反応後
、減圧濃縮し、残渣にエーテルを力■え、生じた沈澱を
濾取した。得られた沈澱をDMF 30mj−THF4
5−に溶かし、0℃冷却下、N−メチルモルホリンでp
H7に調整した。一方、Boc−Gin−0)11.7
7g (7,19gmol)、HOBt 1.21g 
(7,94mmol)をDMF5d−T肝30−の混合
液に溶かし、0℃冷却下N5C−HC11,52g (
7,93mmol)を加え、40分間攪拌した。この溶
液を前記の溶液へ加え、0℃で30分間、低温室(+4
℃)で−晩撹拌した。反応後、析出した沈澱物を濾取し
、減圧濃縮後10%クエン酸水溶液を加え、生じた沈澱
を濾取し、5%重曹水、水の順で洗浄し、目的のBoc
−GlnGln−Tyr(Br−Z)−Ser(Bzl
)−0Pac 5.38g (93,3%)を得た。
Melting point 1164-5°C TLC; 0.39 (C:M:A, 90:10:
1) [α]z5=-3,5@(C-1,0,DhF) Elemental analysis value C! CHN theory as lH3°N206 (%) 62.05 7.44
6.89 Actual value (%) 62.06 7.51 6
.. 76 Reference Example 27 Boc-Gln-Gln-Tr(Br-Z)-Set
(Bzl)-0Pac's 1Boc-Gin-Tyr(B
r-Z)-Set(Bzl)-0Pac 5.51g(
6,00 eamol) was dissolved in 45 mf of 4N hydrochloric acid-dioxane solution under cooling at 0°C, and stirred for 3.5 hours. After the reaction, the mixture was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration. The obtained precipitate was dissolved in DMF 30mj-THF4
5- and diluted with N-methylmorpholine under cooling at 0°C.
Adjusted to H7. On the other hand, Boc-Gin-0) 11.7
7g (7.19gmol), HOBt 1.21g
(7.94 mmol) was dissolved in a mixed solution of DMF5d-T liver 30-, and 11.52 g of N5C-HC (
7.93 mmol) and stirred for 40 minutes. This solution was added to the previous solution and incubated at 0°C for 30 minutes in a cold room (+4°C).
℃) overnight. After the reaction, the precipitate precipitated was collected by filtration, concentrated under reduced pressure, 10% aqueous citric acid solution was added, and the precipitate formed was collected by filtration, washed in the order of 5% aqueous sodium bicarbonate and water to obtain the desired Boc.
-GlnGln-Tyr(Br-Z)-Ser(Bzl
)-0Pac 5.38g (93.3%) was obtained.

融点;  198−201 ’C TLC; 0.27 (C: M :^、90:10:
1)〔α)”=−5,9° (c =1.0. DMF
)元素分析値 C5ollsJJ□・Br−H2O として 理論値(%)56.45 5.59 7.90実測値(
%)  56,56 5.48 7.43参考例28 Boc−Gin−Gln−Tyr(Br−Z)−5er
(Bzl)−0Pac 5.24g(5,OOmmol
)をO″C冷却下4N塩酸−ジオキサン溶液40@lに
溶かし、1時間撹拌した。反応後、減圧濃縮し、残渣に
エーテルを加え、生じた沈澱を濾取した。得られた沈澱
をDMF100@7に溶かし、O″C冷却下、N−メチ
ルモルホリンでpH7に調整した。この溶液に、Boc
−Thr(Bzl)−0H1,86g (6,00nu
wol)、FIOBt 0.93g (6,05emr
iol)を加え、更に一5C−HCl 1.39g (
7,25+nmol)を加え、O″Cで4.5時間、低
温室(+4’C)で−晩撹拌した。反応後、減圧濃縮し
10%クエン酸水溶液を加え、生じた沈澱を濾取し、5
%重曹水、水の順で洗浄した。減圧乾燥後、DMF−酢
酸エチルで沈澱を行い、目的のBoc−Thr(Bzl
)−Gln−Gin−Tyr(Br−Z)−5et(B
zl)−0Pac 5.51g (89,1%)を得た
Melting point; 198-201'C TLC; 0.27 (C: M:^, 90:10:
1) [α)” = -5,9° (c = 1.0. DMF
) Elemental analysis value C5ollsJJ□・Br-H2O Theoretical value (%) 56.45 5.59 7.90 Actual value (
%) 56,56 5.48 7.43 Reference Example 28 Boc-Gin-Gln-Tyr(Br-Z)-5er
(Bzl)-0Pac 5.24g (5,OOmmol
) was dissolved in 40@l of 4N hydrochloric acid-dioxane solution under O''C cooling and stirred for 1 hour. After the reaction, it was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration. The pH was adjusted to 7 with N-methylmorpholine while cooling at O''C. Add Boc to this solution.
-Thr(Bzl)-0H1,86g (6,00nu
wol), FIOBt 0.93g (6,05emr
iol) and further 1.39 g of 5C-HCl (
7,25+nmol) was added and stirred for 4.5 hours at O''C and overnight in a cold room (+4'C). After the reaction, it was concentrated under reduced pressure, a 10% aqueous citric acid solution was added, and the resulting precipitate was collected by filtration. ,5
% sodium bicarbonate solution and then water. After drying under reduced pressure, precipitation is performed with DMF-ethyl acetate to obtain the desired Boc-Thr (Bzl
)-Gln-Gin-Tyr(Br-Z)-5et(B
zl)-0Pac 5.51 g (89.1%) was obtained.

融点; 213−6 ’C TLCiO,39(CAM、 9: 1 )(α) ”
= −t、o”  (c =1.0. DMF)元素分
析値 C61■wJyO+1Br−H2OとしてON 理論値(%)  58,37 5.78 7.81実測
値(%)  58,25 5.63 7.82アミノ酸
分析HThr O,94(1)、 Set 0.91(
1)Gin 2.11(2)、 Tyr 1.04(1
)参考例29 Boc−11e−Phe−OPacの  ゛告HBr 
・H−Phe−OPac 15.2g(41,7mmo
l)をDMF’ 100−に溶かし、−15°C冷却下
、N−メチルモルホリンでp)17に調整した。一方、
Boc41e−Oll ・1/2HzO12,Og (
50,1+mmol)、HOBt 18.3g (11
9mmol)をDMF 150d−THF 250−の
混合液に溶かし、0°C冷却下WSC−)1G111.
3g(58,9mmol)を加え、O℃冷却下40分間
撹拌した。この溶液を前記の溶液へ加え、−20℃で1
時間、0゛Cで1時間、低温室(+4℃)で−晩撹拌し
た。反応後、減圧濃縮し、残渣を酢酸エチル500−に
溶かし、10%クエン酸水溶液、5%重曹水、飽和食塩
水の順で洗浄し、無水硫酸ナトリウムで乾燥した。
Melting point; 213-6'C TLCiO,39(CAM, 9:1)(α)''
= -t, o" (c = 1.0. DMF) Elemental analysis value C61■wJyO+1Br-ON as H2O Theoretical value (%) 58,37 5.78 7.81 Actual value (%) 58,25 5.63 7.82 Amino Acid Analysis HThr O, 94(1), Set 0.91 (
1) Gin 2.11 (2), Tyr 1.04 (1
) Reference example 29 Boc-11e-Phe-OPac's notification HBr
・H-Phe-OPac 15.2g (41.7mmo
l) was dissolved in DMF' 100- and adjusted to p) 17 with N-methylmorpholine while cooling at -15°C. on the other hand,
Boc41e-Oll ・1/2HzO12,Og (
50.1+mmol), HOBt 18.3g (11
9 mmol) was dissolved in a mixed solution of DMF 150d-THF 250- and WSC-)1G111. under cooling at 0°C.
3 g (58.9 mmol) was added and stirred for 40 minutes while cooling at 0°C. This solution was added to the above solution and heated to -20℃ for 1 hour.
The mixture was stirred for 1 hour at 0°C and overnight in a cold room (+4°C). After the reaction, the mixture was concentrated under reduced pressure, and the residue was dissolved in 500% ethyl acetate, washed successively with 10% aqueous citric acid, 5% aqueous sodium bicarbonate, and saturated brine, and dried over anhydrous sodium sulfate.

減圧濃縮後、残渣にエーテルを加え、生じた沈澱を濾取
し、目的のBoc−11e−Phe−OPac12.9
g (70,0%)を得た。
After concentration under reduced pressure, ether was added to the residue, the resulting precipitate was collected by filtration, and the desired Boc-11e-Phe-OPac12.9
g (70.0%) was obtained.

融点i  138.5°C TLC;0.8B (CAM、 9: 1 )(α) 
”= −41,0’  (c=1.0. DMF)元素
分析値 CzsH:+aNzOaとしてHN 理論値(%)  67.72 7.31 5.64実測
値(%)  67.81 7.36 5.64参考例3
0 Boc−Ala−11e−Phe−OPacの Boc
−11e−Phe−OPac 4.96g (10,0
mmol)をO″C冷却下トリフルオロ酢酸10−に溶
かし、1.5時間攪拌した。反応後、減圧濃縮し、残渣
にエーテルを加え、生じた沈澱を濾取した。得られた沈
澱をDMF 25−に溶かし、0℃冷却下、N−メチル
モルホリンでpH7に調整した。一方、Boc−Ala
−0)! 2.27g (12,0mmol) 、ll
0Bt 1.87g (12,2wmol)をDMF 
5af−THF 30−の混合液に溶かし、0℃冷却下
−5C−HCl 2.768 (14,4mmol)を
加え、30分間攪拌した。この溶液を前記の溶液へ加え
、0℃で1時間、低温室(+4℃)で−晩撹拌した。反
応後、減圧濃縮し10%クエン酸水溶液を加え、生じた
沈澱を濾取し、5%重曹水、水の順で洗浄した。減圧乾
燥後、DMF−石油エーテルで沈澱を行い、目的のBo
c−Ala−11e−Phe−OPac5.24g (
92,4%)を得た。
Melting point i 138.5°C TLC; 0.8B (CAM, 9:1) (α)
”= -41,0' (c=1.0. DMF) Elemental analysis value CzsH: +aNzOa as HN Theoretical value (%) 67.72 7.31 5.64 Actual value (%) 67.81 7.36 5 .64 Reference example 3
0 Boc-Ala-11e-Phe-OPac
-11e-Phe-OPac 4.96g (10,0
mmol) was dissolved in 10-trifluoroacetic acid under O''C cooling and stirred for 1.5 hours. After the reaction, it was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration. The resulting precipitate was diluted with DMF. 25- and adjusted the pH to 7 with N-methylmorpholine while cooling at 0°C.
-0)! 2.27g (12.0mmol), ll
0Bt 1.87g (12.2wmol) in DMF
It was dissolved in a mixed solution of 30-5af-THF, and while cooling at 0°C, 2.768 (14.4 mmol) of -5C-HCl was added, followed by stirring for 30 minutes. This solution was added to the previous solution and stirred for 1 hour at 0°C and overnight in a cold room (+4°C). After the reaction, the mixture was concentrated under reduced pressure, a 10% aqueous citric acid solution was added, and the resulting precipitate was collected by filtration and washed in the order of 5% aqueous sodium bicarbonate and water. After drying under reduced pressure, precipitation is performed with DMF-petroleum ether to obtain the desired Bo
c-Ala-11e-Phe-OPac5.24g (
92.4%) was obtained.

融点;  164−4.5℃ TLC:0.62 (CAM、 9: 1)〔α’J 
”−−28,8’  (c =1.0. DMF)元素
分析値 C311141N30?としてCl(N 理論値(%)  65.59 7.28 7.40実測
値(%”)  65.56 7.36 7.55参考例
31 Boc−As (OcHex)−Ala−11e−Ph
e=OPacのBoc−^1a−11e−Phe−OP
ac 5.24g (9,2411111101)をO
℃冷却下トリフルオロ酢酸IQm7に溶かし、1時間攪
拌した。反応後、減圧濃縮し、残渣にエーテルを加え、
生じた沈澱を濾取した。得られた沈澱をDMF 40a
Z−TIIF 5aZに溶かし、0℃冷却下、N−メチ
ルモルホリンでpH7に調整した。
Melting point; 164-4.5°C TLC: 0.62 (CAM, 9:1) [α'J
"--28,8' (c = 1.0. DMF) Elemental analysis value C311141N30? as Cl (N Theoretical value (%) 65.59 7.28 7.40 Actual value (%") 65.56 7. 36 7.55 Reference Example 31 Boc-As (OcHex)-Ala-11e-Ph
e=OPac's Boc-^1a-11e-Phe-OP
ac 5.24g (9,2411111101) O
The mixture was dissolved in trifluoroacetic acid IQm7 while cooling at °C and stirred for 1 hour. After the reaction, concentrate under reduced pressure, add ether to the residue,
The resulting precipitate was collected by filtration. The obtained precipitate was dissolved in DMF 40a.
It was dissolved in Z-TIIF 5aZ and adjusted to pH 7 with N-methylmorpholine while cooling at 0°C.

一方、Boc−Asp(Octlex)−0H3,50
g (11,1mmol)、HOBt 1.70g (
11,1mmo+)をDMF 5aZ−THF 20a
fの混合液に溶かし、θ℃冷却下−SC−HCl 2.
55g (13,3開o1)を加え、1時間攪拌した。
On the other hand, Boc-Asp(Octlex)-0H3,50
g (11.1 mmol), HOBt 1.70 g (
11,1mmo+) in DMF 5aZ-THF 20a
Dissolve in the mixture of f and cool at θ°C with -SC-HCl 2.
55 g (13.3 ml) was added and stirred for 1 hour.

この溶液を前記の溶液へ加え、低温室(+4℃)で−晩
撹拌した。反応後、減圧濃縮し10%クエン酸水溶液を
加え、生じた沈澱を濾取し、5%重曹水、水の順で洗浄
した。減圧乾燥後、DMF−エーテルで沈澱を行い、目
的のBoc−Asp(OcHex)−Ala−11e−
Phe−OPac 5.89g (83,4%)を得た
This solution was added to the previous solution and stirred overnight in a cold room (+4°C). After the reaction, the mixture was concentrated under reduced pressure, a 10% aqueous citric acid solution was added, and the resulting precipitate was collected by filtration and washed in the order of 5% aqueous sodium bicarbonate and water. After drying under reduced pressure, precipitation is performed with DMF-ether to obtain the desired Boc-Asp(OcHex)-Ala-11e-
5.89 g (83.4%) of Phe-OPac was obtained.

融点、  182−2.5℃ TLC,0,67(CAM、  9:  1)〔α) 
”= −23,8”  (c =1.0.  DMF)
元素分析値 C4+HssNJ+o・H2OとしてHN 理論値(%)  63.77 7,35 7.31実測
値(%〉63,71 7.30 7.24参考例32 Boa−Set(Bzl)−As (Octlex)−
Ala−11e−Phe−OPacの盟遣 Boc−Asp(OcHex)−Ala−11e−Ph
e−OPac 4.97g(6,50mmol)を0℃
冷却下トリフルオロ酢酸10mZに溶かし、1時間攪拌
した。反応後、減圧濃縮し、残渣にエーテルを加え、生
じた沈澱を濾取した。
Melting point, 182-2.5℃ TLC, 0.67 (CAM, 9:1) [α)
”=-23,8” (c=1.0.DMF)
Elemental analysis value C4+HssNJ+HN as o・H2O Theoretical value (%) 63.77 7,35 7.31 Actual value (%>63,71 7.30 7.24 Reference example 32 Boa-Set (Bzl)-As (Octlex) −
Ala-11e-Phe-OPac's ally Boc-Asp(OcHex)-Ala-11e-Ph
e-OPac 4.97g (6.50mmol) at 0℃
The mixture was dissolved in 10 mZ of trifluoroacetic acid under cooling and stirred for 1 hour. After the reaction, the mixture was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration.

得られた沈澱をDMF 40−に溶かし、0℃冷却下、
N−メチルモルホリンでpH7に調整した。一方、Bo
c−Set(Bzl)−082,30g (7,79m
mol)、HOBt 1.19g (7,77mmol
)をDMF 5aZ−THF 20−の混合液に溶かし
、0℃冷却下り5C−HCL 1.79g (9,34
mmo+)を加え、1時間攪拌した。この溶液を前記の
溶液へ加え、低温室(+4℃)で−晩撹拌した。
The obtained precipitate was dissolved in DMF 40- and cooled at 0°C.
The pH was adjusted to 7 with N-methylmorpholine. On the other hand, Bo
c-Set (Bzl)-082,30g (7,79m
mol), HOBt 1.19g (7.77mmol
) was dissolved in a mixture of DMF 5aZ-THF 20- and cooled to 0°C. 5C-HCL 1.79g (9,34
mmo+) was added and stirred for 1 hour. This solution was added to the previous solution and stirred overnight in a cold room (+4°C).

反応後、減圧濃縮し10%クエン酸水溶液を加え、生じ
た沈澱を濾取し、5%重曹水、水の順で洗浄した。減圧
乾燥後、D肝−酢酸エチル−エーテルで沈澱を行い、目
的のBoc−Ser(Bzl)−Asp(OcHex)
−^1a−Tie−Phe−OPac 5.90g (
96,3%)を得た。
After the reaction, the mixture was concentrated under reduced pressure, a 10% aqueous citric acid solution was added, and the resulting precipitate was collected by filtration and washed successively with a 5% aqueous sodium bicarbonate solution and water. After drying under reduced pressure, precipitation was performed with D liver-ethyl acetate-ether to obtain the desired Boc-Ser(Bzl)-Asp(OcHex).
-^1a-Tie-Phe-OPac 5.90g (
96.3%) was obtained.

融点;  189−90℃ TLC;0.55 (CAM、 9: 1)〔α) ”
=−19,2° (c =1.0. DMF)元素分析
値 C51H66NSOI□・H2OとしてCHN 理論値(%)  63.87 7.15 7.30実測
値(%)  63.80 7.04 7.30参考例3
3 Boc−3et(Bzl)−Asp(OcHex)−八
la−11e−Phe−OPac5、OOg (5,3
0mmol)をO’c冷却下トリフルオロ酢酸15mZ
に溶かし、1.5時間攪拌した。反応後、減圧濃縮し、
残渣にエーテルを加え、生した沈澱を濾取した。得られ
た沈澱をDMF 25af−TIIF80@1に溶かし
、0°C冷却下、N−メチルモルホリンでpH7に調整
した。’一方、Boc−His (Tos) −OB 
−DCH^7.50g (12,7mmol)をO″C
冷却下10%クエン酸水溶液150−に加えて撹拌後、
酢酸エチル250 @1で抽出し硫酸ナトリウムで乾燥
する。
Melting point; 189-90°C TLC; 0.55 (CAM, 9:1) [α)”
=-19,2° (c = 1.0. DMF) Elemental analysis value CHN as C51H66NSOI□・H2O Theoretical value (%) 63.87 7.15 7.30 Actual value (%) 63.80 7.04 7 .30 Reference example 3
3 Boc-3et(Bzl)-Asp(OcHex)-8la-11e-Phe-OPac5,OOg (5,3
0 mmol) in 15 mZ of trifluoroacetic acid under cooling at O'c.
and stirred for 1.5 hours. After the reaction, concentrate under reduced pressure,
Ether was added to the residue, and the resulting precipitate was collected by filtration. The obtained precipitate was dissolved in DMF 25af-TIIF80@1, and the pH was adjusted to 7 with N-methylmorpholine while cooling at 0°C. 'On the other hand, Boc-His (Tos) -OB
-DCH^7.50g (12.7mmol) in O″C
After adding to 150% of 10% citric acid aqueous solution under cooling and stirring,
Extract with ethyl acetate 250@1 and dry with sodium sulfate.

減圧濃縮し、残渣を塩化メチレン75m7に溶かし、0
°C冷却下DCC1,33g (6,45mmol)を
加え、30分間撹拌した。反応後、析出した沈澱物を濾
取後、減圧濃縮し、残渣をTHP 50−に溶かした。
Concentrate under reduced pressure, dissolve the residue in 75m7 of methylene chloride, and reduce to 0.
While cooling at °C, 1.33 g (6.45 mmol) of DCC was added, and the mixture was stirred for 30 minutes. After the reaction, the precipitate was collected by filtration, concentrated under reduced pressure, and the residue was dissolved in THP 50-.

この溶液を前記の溶液へ加え、低温室(+4°C)で−
晩撹拌した。反応後、減圧濃縮し10%クエン酸水溶液
を加え、生じた沈澱を濾取し、5%重曹水、水の順で洗
浄した。減圧乾燥後、DMF −エーテルで沈澱を行い
、目的のBoc−旧s (Tos)Set(Bzl)−
Asp(OcHex)−Ala−41e−Phe−OP
ac 5.00g(76,5%)を得た。
This solution was added to the above solution and -
Stirred overnight. After the reaction, the mixture was concentrated under reduced pressure, a 10% aqueous citric acid solution was added, and the resulting precipitate was collected by filtration and washed in the order of 5% aqueous sodium bicarbonate and water. After drying under reduced pressure, precipitation is performed with DMF-ether to obtain the desired Boc-old s(Tos)Set(Bzl)-
Asp(OcHex)-Ala-41e-Phe-OP
5.00 g (76.5%) of ac was obtained.

融点、 209−210°C TLC; 0.49 (酢酸エチル:n−ヘキサン、4
:1) 〔α) ”=−10,6’  (c =1.0.  D
MF)元素分析値 C1aFItJeO+5S−H2O
としてHN 理論値(%”)  61.47 6.53 8.96実
測値(%)  60.97 6.62 9.49参考例
34 Boc−His(Tos)−Ser(Bzl)−Asp
(OcHex)−Ala−11e−Phe−OPac 
4.OOg (3,25o+mol)を95%酢酸水溶
液70fi+7に溶かし、活性化した亜鉛末を6.50
g (99,5mmol)を加え、室温で一晩激しく撹
拌した。亜鉛末を濾取した後、減圧濃縮し、残渣に10
%クエン酸水溶液を加え沈澱化し、水で洗浄した。
Melting point, 209-210°C TLC; 0.49 (ethyl acetate: n-hexane, 4
:1) [α) ”=-10,6' (c =1.0.D
MF) Elemental analysis value C1aFItJeO+5S-H2O
HN Theoretical value (%”) 61.47 6.53 8.96 Actual value (%) 60.97 6.62 9.49 Reference example 34 Boc-His(Tos)-Ser(Bzl)-Asp
(OcHex)-Ala-11e-Phe-OPac
4. Dissolve OOg (3,25o+mol) in 95% acetic acid aqueous solution 70fi+7, and add 6.50% activated zinc powder.
g (99.5 mmol) and stirred vigorously at room temperature overnight. After filtering the zinc powder, it was concentrated under reduced pressure, and the residue was
% citric acid aqueous solution was added to precipitate, and the mixture was washed with water.

減圧乾燥後、DMF−酢酸エチルで、再沈澱し、目的の
Boc−His(Tos)−5er(Bzl)−Asp
 (Oc)lex)−^1a−1ie−Phe−OR3
,16g (87,4%)を得た。
After drying under reduced pressure, reprecipitation was performed with DMF-ethyl acetate to obtain the desired Boc-His(Tos)-5er(Bzl)-Asp.
(Oc)lex)-^1a-1ie-Phe-OR3
, 16g (87.4%) were obtained.

融点、  217−9°C TLC;0.77 (B:A:W、4 : 1 : 5
)(α) ”=−13,5″’  (c=1.0.0M
5O)元素分析値 C5JtJsO□・DMF・3/2+i、oとして理論
値(%)  58,35 6.89 10.38実測値
(%)58.34 7.11 11.11アミノ酸分析
; Asp 1.07(1)、 Ser 1.05(1
)Ala  1.00(1)、  lie O,9B(
1)Phe O,98(1)、 His 0.95(1
)参考例35 盈 Boc−Thr(Bzl)−Gln−Gln−Tyr(
Br−Z)−3et(Bzl)−OPac 3.99g
 (3,21mmol)を、0°C冷却下4N塩酸−ジ
オキサン溶液24m1に溶かし、2時間撹拌した。反応
後、減圧濃縮し、残渣にエーテルを加え、生じた沈澱を
濾取した。得られた沈澱を0MF27−に溶かし、O′
C冷却下、N−メチルモルホリンでpH7に調整した。
Melting point, 217-9°C TLC; 0.77 (B:A:W, 4:1:5
)(α) ”=-13,5″’ (c=1.0.0M
5O) Elemental analysis value C5JtJsO□・DMF・3/2+i, o Theoretical value (%) 58,35 6.89 10.38 Actual value (%) 58.34 7.11 11.11 Amino acid analysis; Asp 1. 07(1), Ser 1.05(1)
)Ala 1.00(1), lie O,9B(
1) Phe O, 98 (1), His 0.95 (1)
) Reference Example 35 Boc-Thr(Bzl)-Gln-Gln-Tyr(
Br-Z)-3et(Bzl)-OPac 3.99g
(3.21 mmol) was dissolved in 24 ml of 4N hydrochloric acid-dioxane solution under cooling at 0°C and stirred for 2 hours. After the reaction, the mixture was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration. The obtained precipitate was dissolved in 0MF27- and O'
The pH was adjusted to 7 with N-methylmorpholine under cooling.

この溶液に、Boc−His−Ser(Bzl)−As
p(OcHex)−^1a−Tle−Phe−OH3,
81g(3,42mmol)、tlOBt 0.65g
 (4,27mmol)の叶F 30aZ−DMSO1
5af溶液を加え、更にO″C冷却下WSC・HCl 
0.98 g (5,12mmol)のD肝溶液30−
を加え、0℃で冷却下1時間、低温室(+4°C)で−
晩撹拌した。反応後、減圧濃縮し、残渣に10%クエン
酸水溶液を加え、生じた沈澱物を5%重曹水、水の順で
洗浄した。減圧乾燥後、メタノールで再結晶し、目的の
Boc−His−Ser(Bzl)−Asp (OcH
ex) −Ala−1ie−Phe−Thr (Bz 
1)−Gin−Gin−Tyr(Br−Z)−Set(
Bzl)−0Pac 6.36g (95,2%)を得
た。
In this solution, Boc-His-Ser(Bzl)-As
p(OcHex)-^1a-Tle-Phe-OH3,
81g (3.42mmol), tlOBt 0.65g
(4,27 mmol) Leaf F 30aZ-DMSO1
Add 5af solution and add WSC/HCl under O″C cooling.
0.98 g (5,12 mmol) of D liver solution 30-
and cooled at 0°C for 1 hour, then in a cold room (+4°C) -
Stirred overnight. After the reaction, the mixture was concentrated under reduced pressure, a 10% aqueous citric acid solution was added to the residue, and the resulting precipitate was washed successively with a 5% aqueous sodium bicarbonate solution and water. After drying under reduced pressure, it is recrystallized with methanol to obtain the desired Boc-His-Ser(Bzl)-Asp (OcH
ex) -Ala-1ie-Phe-Thr (Bz
1)-Gin-Gin-Tyr(Br-Z)-Set(
6.36 g (95.2%) of Bzl)-0Pac were obtained.

融点;248°C(分解) TLC;0.70 (B:A:W、4 : 1 : 5
)(α) ”= −4,0’  (c=0.5.0M5
O)元素分析値 C+osH+tJ+50g5Br ・
311tOとしてHN 理論値(%)  59,12 6.28 9.85実測
値(%)  59.06 5.93 9.61アミノ酸
分析;^sp 1.06(1)、 Thr 1.0H1
)Set 1.94(2)、 Gin 2.30(2)
Ala 0.99(1)、 lie O,76(1)T
yr 1.15(1)、 Phe O,86(1)Hi
s  O,92(1) 参考例36 Boc−His−Ser(Bzl)−Asp (OcH
ex)−^1a−Tie−PheThr(Bzl)−G
in−Gin−Tyr(Br−Z)−3et(Bzl)
 −0Pac3.44g (1,75開o1)を、N−
メチルピロリドン15−一酢酸300 @7の混合液に
溶かし、活性化した亜鉛末を5.65g (86,5m
mo+)を加え、室温で7.5時間激しく撹拌した。亜
鉛末を濾取した後、酢酸を減圧留去し、残渣に、10%
クエン酸水溶液を加え沈澱化し、水に洗浄した。減圧乾
燥後、エーテルで洗浄し、目的のBoc−His−3e
r(Bzl)−Asp(OcHex)−Ala−11e
−Phe−Thr(Bzl)−Gin−Gin−Tyr
(Br−Z)−5et(13zl)−081,28g 
(41,2%)を得た。
Melting point: 248°C (decomposition) TLC: 0.70 (B:A:W, 4:1:5
)(α) ”= −4,0' (c=0.5.0M5
O) Elemental analysis value C+osH+tJ+50g5Br ・
HN as 311tO Theoretical value (%) 59.12 6.28 9.85 Actual value (%) 59.06 5.93 9.61 Amino acid analysis; ^sp 1.06 (1), Thr 1.0H1
) Set 1.94 (2), Gin 2.30 (2)
Ala 0.99(1), lie O,76(1)T
yr 1.15 (1), Phe O, 86 (1) Hi
s O,92(1) Reference Example 36 Boc-His-Ser(Bzl)-Asp(OcH
ex)-^1a-Tie-PheThr(Bzl)-G
in-Gin-Tyr(Br-Z)-3et(Bzl)
-0Pac3.44g (1,75 open o1), N-
5.65 g (86.5 m
mo+) was added and stirred vigorously at room temperature for 7.5 hours. After filtering the zinc dust, acetic acid was distilled off under reduced pressure, and the residue was
A citric acid aqueous solution was added to precipitate the mixture, which was washed with water. After drying under reduced pressure, wash with ether to obtain the desired Boc-His-3e.
r(Bzl)-Asp(OcHex)-Ala-11e
-Phe-Thr(Bzl)-Gin-Gin-Tyr
(Br-Z)-5et(13zl)-081,28g
(41.2%) was obtained.

融点;247°C(分解) TLC; 0.21 (C: M :^、9:2:1)
〔α) ”=+3.0”  (c =0.1.0M5O
)元素分析値 CwJtttN+5OzJr + ci
tric acid・11H20として 理論値(%) 実測値(%) アミノ酸分析; Asp Ser Ala Tyr is CH 52,616,47 52,245,80 1,02(1)、  Thr 1.76(2)、  Gln 1.06(1)、  l1e 1.02(1)、  Phe O,9H1) 参考例37 8.94 9.03 1.00(1) 2.19(2) 0.99(1) 1.04 (1) 盟遺 Boc−5et(Bzl)−Arg(Mts)−Thr
(Bzl)−5et(Bzl)−Pro−Pro−Pr
o−N41t 4.OOg (3,09mmol)を、
O°c冷却下トリフルオロ酢酸10m7に溶かし、2時
間撹拌した。反応後、減圧濃縮し、残渣にエーテルを加
え、生じた沈澱を濾取した。得られた沈澱をD肝15W
L1に溶かし、O″C冷却下、N−メチルモルホリンで
pH7に調整した。この溶液に、Boc−^1a−Se
t(Bzl)−11e−Leu−Gly−OH2,41
g (3,71ma+ol) 、HOBL 0.56g
 (3,71sv+ol)のDMF 20−溶液を加え
、更に0°C冷却下−SC−ICl 0.86g(4,
49mmol)のDMF溶液15mfを加え、O′Cで
冷却下2時間、低温室(+4°C)で−晩撹拌した。反
応後、減圧濃縮し、残渣に10%クエン酸水溶液を加え
、生じた沈澱物を5%重曹水、水の順で洗浄した。減圧
乾燥後、この沈澱物を5ephadex LH−20の
カラムクロマト(3,2X55cm)にアプライし、溶
出溶媒97%DMF (DMF :水、97:3)を用
いるカラムクロマトグラフィーにより精製した。
Melting point: 247°C (decomposition) TLC: 0.21 (C: M:^, 9:2:1)
[α) ”=+3.0” (c =0.1.0M5O
) Elemental analysis value CwJtttN+5OzJr + ci
Theoretical value (%) as tric acid 11H20 Actual value (%) Amino acid analysis; Asp Ser Ala Tyr is CH 52,616,47 52,245,80 1,02 (1), Thr 1.76 (2), Gln 1.06(1), l1e 1.02(1), Phe O,9H1) Reference example 37 8.94 9.03 1.00(1) 2.19(2) 0.99(1) 1.04 (1) Boc-5et (Bzl)-Arg (Mts)-Thr
(Bzl)-5et(Bzl)-Pro-Pro-Pr
o-N41t 4. OOg (3.09 mmol),
The mixture was dissolved in 10 m7 of trifluoroacetic acid under cooling at O°C and stirred for 2 hours. After the reaction, the mixture was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration. The obtained precipitate was heated to D liver 15W.
Boc-^1a-Se was dissolved in Boc-^1a-Se.
t(Bzl)-11e-Leu-Gly-OH2,41
g (3,71ma+ol), HOBL 0.56g
(3,71 sv+ol) of DMF 20-solution was added and further cooled at 0°C -SC-ICl 0.86 g (4,
49 mmol) of DMF solution was added thereto, and the mixture was stirred for 2 hours under cooling at O'C and overnight in a cold room (+4°C). After the reaction, the mixture was concentrated under reduced pressure, a 10% aqueous citric acid solution was added to the residue, and the resulting precipitate was washed successively with a 5% aqueous sodium bicarbonate solution and water. After drying under reduced pressure, the precipitate was applied to a 5ephadex LH-20 column chromatograph (3.2×55 cm) and purified by column chromatography using an eluent of 97% DMF (DMF:water, 97:3).

3gずつ分画し、24−60本目を集め、減圧濃縮し、
エーテルを加え、析出した沈澱を濾取し、目的のBoc
−^1a−Ser(Bzl)−11e−Leu−Gly
−3er(Bzl)−Arg (Mts) 、Thr 
(Bz l) −Set (Bz l) −Pro−P
ro−Pro−NH14,86g (86,1%)を得
た。
Fractionate 3g each, collect 24th to 60th fractions, concentrate under reduced pressure,
Add ether and collect the precipitate by filtration to obtain the desired Boc.
-^1a-Ser(Bzl)-11e-Leu-Gly
-3er(Bzl)-Arg(Mts), Thr
(Bz l) -Set (Bz l) -Pro-P
86 g (86.1%) of ro-Pro-NH14 was obtained.

融点;  220−3℃ TLCio、75 (BAA:W、4 : 1 : 5
)〔α) ” −−27,1@(c =0.1.0M5
O)元素分析値 CwsH+sJ+10zoS ・4H
zOとしてC)l 理論値(%)  58.91 7.33実測値(%) 
 59.07 7.13アミノ酸分析; Thr O,
99(1)、 5erGly 1.00(1)、  T
ie Leu  1.02(1)、  八rgPro 2.6
3(3) 11.82 12.01 2.67(3) 0.97(1) 1.08(1) 参考例38 Boc−Ala−Ser(Bzl)−11e−Leu−
Gly−Ser(Bzl)−Arg(Mts)−Thr
(Bzl)−3et(Bzl) −Pro−Pro−P
ro−Ntlz3.39g (1,86mmol)を、
O℃冷却下トリフルオロ酢酸10mZに溶かし、2時間
撹拌した。反応後、減圧濃縮し、残渣にエーテルを加え
、生じた沈澱を濾取した。得られた沈澱をDMF 40
aZ−0MSO35−に溶かし、0°C冷却下、N−メ
チルモルホリンでpH7に調整した。この溶液に、Bo
c−LeuGln−Lys(Cl−Z)−Tyr(Br
−Z)−Leu−OH2,55g (2,23mmol
) 、HOBt O,35g (2,29ma+ol)
のDMF 25−溶液を加え、更に0°C冷却下−SC
−)ICl O,51g(2,66m1lO1)のDM
F溶液10−を加え、0°Cで冷却下3時間、低温室(
+4°C)で−晩撹拌した。
Melting point; 220-3°C TLCio, 75 (BAA:W, 4:1:5
) [α) ” −−27,1@(c =0.1.0M5
O) Elemental analysis value CwsH+sJ+10zoS ・4H
C)l as zO Theoretical value (%) 58.91 7.33 Actual value (%)
59.07 7.13 Amino acid analysis; Thr O,
99(1), 5erGly 1.00(1), T
ie Leu 1.02(1), 8rgPro 2.6
3(3) 11.82 12.01 2.67(3) 0.97(1) 1.08(1) Reference example 38 Boc-Ala-Ser(Bzl)-11e-Leu-
Gly-Ser(Bzl)-Arg(Mts)-Thr
(Bzl)-3et(Bzl) -Pro-Pro-P
ro-Ntlz3.39g (1.86mmol),
The mixture was dissolved in 10 mZ of trifluoroacetic acid while cooling at 0°C and stirred for 2 hours. After the reaction, the mixture was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration. The obtained precipitate was dissolved in DMF 40
It was dissolved in aZ-0MSO35-, and the pH was adjusted to 7 with N-methylmorpholine while cooling at 0°C. In this solution, Bo
c-LeuGln-Lys(Cl-Z)-Tyr(Br
-Z)-Leu-OH2,55g (2,23mmol
), HOBt O, 35g (2,29ma+ol)
Add a DMF 25-solution and further cool at 0°C-SC
-) DM of ICl O, 51 g (2,66 ml O1)
F solution 10- was added and kept at 0°C for 3 hours in a cold room (
+4°C) overnight.

反応後、減圧濃縮し、残渣に10%クエン酸水溶液を加
え、生じた沈澱物を5%重曹水、水の順で洗浄した。減
圧乾燥後、N−メチルピロリドン−メタノールで再沈澱
し、目的のBoc−Leu−Gin−Lys(Cl−Z
)−Tyr(Br−Z)−Leu−Ala−Ser (
Bzl)−11e−Leu−Gly−Ser(Bzl)
−Arg (Mts)−Thr(Bzl)−3et(B
zl)−Pro−Pro−Pro−NHx 4.78g
 (90,1%)を得た。
After the reaction, the mixture was concentrated under reduced pressure, a 10% aqueous citric acid solution was added to the residue, and the resulting precipitate was washed successively with a 5% aqueous sodium bicarbonate solution and water. After drying under reduced pressure, reprecipitation was performed with N-methylpyrrolidone-methanol to obtain the desired Boc-Leu-Gin-Lys (Cl-Z
)-Tyr(Br-Z)-Leu-Ala-Ser (
Bzl)-11e-Leu-Gly-Ser(Bzl)
-Arg(Mts)-Thr(Bzl)-3et(B
zl)-Pro-Pro-Pro-NHx 4.78g
(90.1%) was obtained.

融点;286°C(分解) TLC;0.75 (B:A:W、4 : 1 : 5
)〔α) ”=−18,3@(c =1.0. DMS
O)元素分析値 CraH+qNzxOs+−Cl−B
r−S ・2JOとして CHN 理論値(%’)  5B、65 6.81 11.16
実測値(%)  58.76 6.91 11.38ア
ミノ酸分析; Thr O,99(1) 。
Melting point: 286°C (decomposition) TLC: 0.75 (B:A:W, 4:1:5
) [α) ”=-18,3@(c=1.0.DMS
O) Elemental analysis value CraH+qNzxOs+-Cl-B
r-S ・CHN as 2JO Theoretical value (%') 5B, 65 6.81 11.16
Actual value (%) 58.76 6.91 11.38 Amino acid analysis; Thr O, 99 (1).

Gin  1.04(1)。Gin 1.04 (1).

Ala  1.02(1)。Ala 1.02 (1).

Leu 3.30(3)。Leu 3.30(3).

Lys 1.10(1)。Lys 1.10(1).

Pro 2.68(3) Set 2.60(3) Gly 1.03(1) 11e  1.04(1) Tyr 1.IHl、) Arg 1.08(1) 参考例39 Boc−Leu−Gln−Lys(Cl−Z)−Tyr
(Br−Z)−Leu−Ala−Ser(Bzl)−1
1e−Leu−Gly−Set(Bzl)−Arg(M
ts) −Thr(Bzl)−Set(Bzl)−Pr
o−Pro−Pro−NHz 4.00g  (1,4
0mmol)を、O″C冷却下トリフルオロ酢酸10−
に溶かし、2時間撹拌した。反応後、減圧濃縮し、残渣
にエーテルを加え、生じた沈澱を濾取した。
Pro 2.68 (3) Set 2.60 (3) Gly 1.03 (1) 11e 1.04 (1) Tyr 1. IHl, ) Arg 1.08 (1) Reference Example 39 Boc-Leu-Gln-Lys(Cl-Z)-Tyr
(Br-Z)-Leu-Ala-Ser(Bzl)-1
1e-Leu-Gly-Set(Bzl)-Arg(M
ts) -Thr(Bzl)-Set(Bzl)-Pr
o-Pro-Pro-NHz 4.00g (1,4
0 mmol) was added to trifluoroacetic acid 10-
and stirred for 2 hours. After the reaction, the mixture was concentrated under reduced pressure, ether was added to the residue, and the resulting precipitate was collected by filtration.

得られた沈澱をDMF 20mj−IIMSO45wL
Iに溶かし、0°C冷却下、N−メチルモルホリンでp
H7に調整した。この溶液に、Boc−Lys (Cl
−Z)−Leu−Leu−^1a−Lys(Cl−Z)
−Leu−Ala−OH2,OOg (1,68mmo
l)、HOBt O,39g (2,55問01)のD
MF Loa&溶液を加え、更にO″C冷却下−5C−
HCl 0.50g (2’、62+++mol)を加
え、低温室(+4°C)で2日間撹拌した。反応後、減
圧濃縮し、残渣に10%クエン酸水溶液を加え、生じた
沈澱物を5%重曹水、水の順で洗浄した。減圧乾燥後、
DMSO−メタノールで再沈澱し、目的のBoc−Ly
s(C1−Z)−Leu−Leu−Ala−Lys(C
l−Z)−Leu−^1a−Leu−Gin−Lys 
(Cl−Z) −Tyr (Br−Z)−Leu−^1
a−3er(Bzl)−11e−Leu−Gly−Se
t(Bzl)−Arg(Mts)−Thr(Bzl)−
Set(Bzl)−Pro−Pro−Pro−NHt 
4.14g (75,3%)を得た。
The obtained precipitate was added to DMF 20mj-IIMSO45wL.
I, and diluted with N-methylmorpholine under cooling at 0°C.
Adjusted to H7. Add Boc-Lys (Cl
-Z) -Leu-Leu-^1a-Lys(Cl-Z)
-Leu-Ala-OH2,OOg (1,68mmo
l), HOBt O, 39g (2,55 question 01) D
Add MF Loa & solution and further cool at O″C -5C-
0.50 g (2', 62+++ mol) of HCl was added and stirred in a cold room (+4°C) for 2 days. After the reaction, the mixture was concentrated under reduced pressure, a 10% aqueous citric acid solution was added to the residue, and the resulting precipitate was washed successively with a 5% aqueous sodium bicarbonate solution and water. After drying under reduced pressure,
Reprecipitate with DMSO-methanol to obtain the desired Boc-Ly.
s(C1-Z)-Leu-Leu-Ala-Lys(C
l-Z)-Leu-^1a-Leu-Gin-Lys
(Cl-Z) -Tyr (Br-Z)-Leu-^1
a-3er(Bzl)-11e-Leu-Gly-Se
t(Bzl)-Arg(Mts)-Thr(Bzl)-
Set(Bzl)-Pro-Pro-Pro-NHt
4.14 g (75.3%) were obtained.

融点;295°C(分解) TLC;0.61 CB:A:H,4: 1 : 5)
〔α〕“= −20,7”  (C=1.0.0M5O
)元素分析値 C+++5Hzi++N+zOnzC1
+BrS ・6HzOとしてClI      N 理論値(%)  57.45 6.99 11.11実
測値(%)  57.21 6.52 11.03アミ
ノ酸分析;T、hr 1.00(1)、 Set 2.
66(3)Gin 1.03(1)、  Gly 1.
06(1)Ala 2.96(3)、  lie 1.
06(1)Leu 6.46(6)、  Tyr 1.
IHl)Lys 2.9H3)、  Arg 1.09
(1)Pro 2.67(3)
Melting point: 295°C (decomposition) TLC: 0.61 CB:A:H, 4: 1: 5)
[α] “= −20,7” (C=1.0.0M5O
) Elemental analysis value C+++5Hz++N+zOnzC1
+BrS ClI N as 6HzO Theoretical value (%) 57.45 6.99 11.11 Actual value (%) 57.21 6.52 11.03 Amino acid analysis; T, hr 1.00 (1), Set 2.
66(3)Gin 1.03(1), Gly 1.
06(1)Ala 2.96(3), lie 1.
06(1)Leu 6.46(6), Tyr 1.
IHl)Lys 2.9H3), Arg 1.09
(1) Pro 2.67 (3)

【図面の簡単な説明】[Brief explanation of drawings]

図1はラットおよびモルモット心房筋に対するヘロデル
ミンの作用を示すグラフ、図2はモルモット気管筋に対
するヘロデルミンの作用を示すグラフ、図3はモルモッ
ト回腸に対するヘロデル旦ンの作用を示すグラフ、図4
は家兎胸部大動脈に対するヘロデルミンの作用を示すグ
ラフである。
Figure 1 is a graph showing the effect of helodermin on rat and guinea pig atrial muscle, Figure 2 is a graph showing the effect of helodermin on guinea pig tracheal muscle, Figure 3 is a graph showing the effect of herodermin on guinea pig ileum, and Figure 4.
is a graph showing the effect of helodermin on the rabbit thoracic aorta.

Claims (1)

【特許請求の範囲】 1 次の構造式 【遺伝子配列があります】 で表されるペプチド(ヘロデルミン)を主成分とする喘
息治療薬。 2 次の構造式 【遺伝子配列があります】 (式中、Bocはターシャリーブチルオキシカルボニル
基、Bzlはベンジル基、OcHexはシクロヘキシル
エステル基、Br−Zは2−ブロモベンジルオキシカル
ボニル基、Cl−Zは2−クロロベンジルオキシカルボ
ニル基、X_1はトシル基または水素原子、X_2はト
シル基またはメシチレン−2−スルフォニル基を示す。 ) で示されるペプチドの保護基を除去することを特徴とす
るヘロデルミンの製造方法。 3 保護基を強酸により除去する請求項2記載のヘロデ
ルミンの製造方法。 4 保護基をフッ化水素により除去する請求項2記載の
ヘロデルミンの製造方法。 5 保護基をトリフルオロメタンスルフォン酸により除
去する請求項2記載のヘロデルミンの製造方法。 6 次の構造式 【遺伝子配列があります】 【遺伝子配列があります】 (式中、Bocはターシャリーブチルオキシカルボニル
基、Bzlはベンジル基、OcHexはシクロヘキシル
エステル基、Br−Zは2−ブロモベンジルオキシカル
ボニル基、Cl−Zは2−クロロベンジルオキシカルボ
ニル基、X_1はトシル基または水素原子、X_2はト
シル基またはメシチレン−2−スルフォニル基を示す。 ) で示されるペンタトリアコサペプチドアミド。 7 次の構造式 【遺伝子配列があります】 (式中、Bocはターシャリーブチルオキシカルボニル
基、Bzlはベンジル基、OcHexはシクロヘキシル
エステル基、Br−Zは2−ブロモベンジルオキシカル
ボニル基、X_1はトシル基または水素原子を示す) で示されるウンデカペプチドを、次の構造式【遺伝子配
列があります】 (式中、Cl−Zは2−クロロベンジルオキシカルボニ
ル基、X_2はトシル基またはメシチレン−2−スルフ
ォニル基を示す) で示されるテトラコサペプチドアミドと縮合させること
を特徴とする次の構造式 【遺伝子配列があります】 で示されるペンタトリアコサペプチドアミドの製造方法
[Claims] 1. An asthma treatment whose main ingredient is a peptide (herodermin) represented by the following structural formula [gene sequence is included]. 2 The following structural formula [Gene sequence is available] (In the formula, Boc is a tertiary butyloxycarbonyl group, Bzl is a benzyl group, OcHex is a cyclohexyl ester group, Br-Z is a 2-bromobenzyloxycarbonyl group, Cl-Z is a 2-chlorobenzyloxycarbonyl group, X_1 is a tosyl group or a hydrogen atom, and X_2 is a tosyl group or a mesitylene-2-sulfonyl group. Method. 3. The method for producing herodermine according to claim 2, wherein the protecting group is removed with a strong acid. 4. The method for producing helodermine according to claim 2, wherein the protecting group is removed with hydrogen fluoride. 5. The method for producing herodermine according to claim 2, wherein the protecting group is removed with trifluoromethanesulfonic acid. 6 The following structural formula [There is a gene sequence] [There is a gene sequence] A pentatriacosapeptide amide represented by a carbonyl group, Cl-Z is a 2-chlorobenzyloxycarbonyl group, X_1 is a tosyl group or a hydrogen atom, and X_2 is a tosyl group or a mesitylene-2-sulfonyl group. 7 The following structural formula [Gene sequence is available] (In the formula, Boc is a tert-butyloxycarbonyl group, Bzl is a benzyl group, OcHex is a cyclohexyl ester group, Br-Z is a 2-bromobenzyloxycarbonyl group, and X_1 is a tosyl group. The undecapeptide represented by the following structural formula [gene sequence available] (in which Cl-Z is a 2-chlorobenzyloxycarbonyl group, and A method for producing pentatriacosapeptide amide represented by the following structural formula [gene sequence is available], which is characterized by condensation with tetracosapeptide amide represented by (indicating a sulfonyl group).
JP1226851A 1989-09-01 1989-09-01 Production of helodermin and use thereof Pending JPH0390034A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1226851A JPH0390034A (en) 1989-09-01 1989-09-01 Production of helodermin and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1226851A JPH0390034A (en) 1989-09-01 1989-09-01 Production of helodermin and use thereof

Publications (1)

Publication Number Publication Date
JPH0390034A true JPH0390034A (en) 1991-04-16

Family

ID=16851561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1226851A Pending JPH0390034A (en) 1989-09-01 1989-09-01 Production of helodermin and use thereof

Country Status (1)

Country Link
JP (1) JPH0390034A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19535973A1 (en) * 1995-09-27 1997-04-10 Max Planck Gesellschaft Medicament containing helodermin fragment
JP2002293799A (en) * 2001-03-29 2002-10-09 Itoham Foods Inc New peptide and enterokinesis inhibitor containing the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61118399A (en) * 1984-11-14 1986-06-05 Otsuka Pharmaceut Co Ltd Production of peptide hormone
JPS63287797A (en) * 1987-05-18 1988-11-24 M D Res Kk Production of octacosapeptide
JPS63287798A (en) * 1987-05-18 1988-11-24 M D Res Kk Protected peptide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61118399A (en) * 1984-11-14 1986-06-05 Otsuka Pharmaceut Co Ltd Production of peptide hormone
JPS63287797A (en) * 1987-05-18 1988-11-24 M D Res Kk Production of octacosapeptide
JPS63287798A (en) * 1987-05-18 1988-11-24 M D Res Kk Protected peptide

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19535973A1 (en) * 1995-09-27 1997-04-10 Max Planck Gesellschaft Medicament containing helodermin fragment
JP2002293799A (en) * 2001-03-29 2002-10-09 Itoham Foods Inc New peptide and enterokinesis inhibitor containing the same

Similar Documents

Publication Publication Date Title
US4415558A (en) CRF And analogs
FI83660B (en) Process for the preparation of human pancreatic GRF
EP0034259B1 (en) Peptides, process for their preparation and medicaments or diagnostic agents containing them
EP0067425B1 (en) Possibly protected peptides, process for their preparation and pharmaceutical agents containing them
US4316891A (en) Extended N-terminal somatostatin
US4517181A (en) Mammalian PGRF
JPH0680079B2 (en) Polypeptide
JPH0680076B2 (en) Acid-protease inhibitory peptide derivative
EP0552238A1 (en) Cyclopeptides, a method of preparing them, and their use as drugs
JPH0269499A (en) Cyclic grf analogue
JP2508755B2 (en) Peptide attractant and method for producing the same
KR100251496B1 (en) Hexapeptide
CA2072253A1 (en) Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
KR890002774B1 (en) Hentetracontapeptide crf and analogs
JP3311800B2 (en) Novel derivatives of vasoactive intestinal peptides
JPH0390034A (en) Production of helodermin and use thereof
US4908352A (en) Urotensin peptides
FI94421C (en) A method for preparing therapeutically useful peptides
EP0107890B1 (en) Mammalian pgrf
FR2595705A1 (en) GONADOLIBERIN DERIVATIVES CONTAINING AROMATIC AMINOCARBOXYLIC ACID IN POSITION 6, PHARMACEUTICAL AND VETERINARY COMPOSITIONS CONTAINING SAME AND PROCESS FOR PREPARING THE SAME
JPH0692991A (en) New active peptide
WO1990003393A1 (en) Crf analogs
WO1991014446A1 (en) Crf analogs
JP3354173B2 (en) Polypeptides and uses thereof
DE3205991A1 (en) POLYPEPTIDES, METHOD FOR THE PRODUCTION THEREOF, THE USE THEREOF AND METHOD FOR CLEANING POLYPEPTIDES